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Abstract
This study examined the prevalence rate of obstructive sleep apnea (OSA) as an
independent variable in association with hypertension as an outcome. Studies conducted
outside of the United States suggest that differences in craniofacial features among
middle-aged Asians increase the prevalence of OSA in comparison to Caucasians with
similar age and lower BMI. No similar study had been conducted in the United States.
The sufficient component cause theory guided this study and was able to describe the
association between OSA and hypertension among middle-aged Asians. The objective of
this cross sectional retrospective study was to determine the prevalence rate of OSA and
the association between OSA and hypertension among a sample of 462 middle-aged
Asian patients. Also, the study evaluated the association of 8 clinical parameters: age,
gender, smoking, body mass index, Mallampati score, Epworth Sleepiness Scale and
Apnea-Hypopnea-Index, and hypertension. The logistic regression analysis showed that
OSA is associated with hypertension. The model containing the 8 variables was
statistically significant, x2 (8, N = 462) = 139.59, p < .000). Age was the strongest
predictor among the 8 variables. This study showed that OSA is common among middleage Asians. This research may necessitate the need to evaluate to change current medical
awareness, diagnosis, and treatment of OSA and hypertension among Asians, which
could reduce the cardiovascular disease (CVD) morbidity and mortality.
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Chapter 1: Introduction to the Study
Introduction
Hypertension, the most important modifiable and major risk factor for adverse
cardiovascular disease (CVD) affects approximately 70 million people in the United
States (Roger et al., 2012). However, it has been suggested that some racial and ethnic
groups have much higher rates of hypertension than the general population (Mirrakhimov
et al., 2013; Yoon et al., 2010). These variations in prevalence in cardiovascular risk
factors also occur among subgroups (Egan et al., 2010). Hypertension prevalence rates
differ among subgroups of the Asian population (Watson et al., 2009). In the
MultiEthnic Study of Atherosclerosis (MESA study), the rate of hypertension among
Chinese (n = 803) was 35.2 (Moran et al., 2007). The Pan Asian Cohort Study (2013)
revealed that the age-and sex-adjusted prevalence rate of hypertension among various
Asian subgroups compared to Non-Hispanic Whites using electronic medical records of
216,768 patients over 18 years of age was 34.9% (99% CI, 34.5-35.3%) versus 38.9%
(99% CI, 38.6-39.2%; Powell et al., 2013). The adjusted hypertension rates were 51.2 %
(50.7-53.2%) for Filipinos, 29.8% (29.1-30.4%) for Chinese, 30.7% (28.0-33.5%) for
Koreans, 30.8% (28.7-32.8%) for Vietnamese, 36.9% (35.9-37.8%) for Asian Indians,
and 38.2% (36.5-39.9%) for Japanese (Powell et al., 2013, p. 10). These variations in
cardiovascular risk factors associated with hypertension are obviously modulated by
race/ethnicity and prevalent comorbidities (Aronow et al., 2011).
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Evidence suggested that hypertension is highly prevalent among obstructive sleep
apnea (OSA) patients (Baguet et al., 2006). Numerous studies have confirmed that the
intermittent airway occlusion exhibited during nocturnal sleep typical in obstructive sleep
apnea evoked acute transient increases in nighttime blood pressure which consequently
produced sustained daytime hypertension (Borgel et al., 2004). Studies have shown that
about 30%-40% of hypertensives have some form of OSA (Worsnop et al., 1998).
Systemic hypertension is also prevalent among an estimated 50%-60% of OSA patients
(Silverberg et al., 2001). Additionally, 40% of patients with systemic hypertension have
undiagnosed OSA (Silverberg et al., 1997).
In the last few decades, studies throughout the world have led to the recognition
that the many mechanisms linking hypertension significantly affect the
pathophysiological mechanisms of OSA (Kapa et al., 2008; Lopez-Jimenez et al., 2008;
McNicholas et al., 2007; Quan & Gersh, 2004). Both OSA and hypertension are complex
disorders modulated by a number of risk factors (Villanueva et al., 2005). Race is an
important risk factor in development of OSA and hypertension (Yaggi & Strohl, 2010).
Asians are contemporarily classified as Asians/ Pacific Islanders in the United States
(Villanueva et al., 2005, p. 420). Such national descriptors do not accurately convey
genetic variation in the prevalence of hypertension among middle aged Asians with OSA.
Moreover, craniofacial structure is an important and often ignored risk factor among
Asians (Villanueva et al., 2005, p. 21). Interethnic comparison in craniofacial
morphology might be used to explain any variation in risk for OSA-hypertension.
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The next few sections of Chapter 1 cover the study’s background, problem
statement, purpose, research questions and hypotheses, theoretical framework, nature,
definitions, assumptions, scope and delimitations.
Background
In the years following early notions concerning whether OSA is an independent
risk factor for hypertension, numerous large epidemiologic studies provided substantial
proof that OSA does increase the risk for hypertension (Punjabi, 2008). The Sleep Heart
Study, a cross-sectional study of 6,132 patients aged 40 and above, by employing inhome polysomnography, showed that in a significant number of patients, OSA was
independently associated with hypertension (Nieto et al., 2000). The association,
although quite modest, revealed that adjusted odds ratio for AHI > 30 (versus AHI < 1.5)
was 1.37 (95% CI 1.03-1.83; Nieto et al., 2000, p. 1832). The Wisconsin Heart Study, a
prospective study using in-laboratory polysomnography, also demonstrated that OSA was
associated with hypertension. The Wisconsin study also revealed that the adjusted odds
ratio of OSA (AHI > 30) to hypertension was 3.1 (95% CI 1.7-5.7; Nieto et al., 2000, p.
1832). Furthermore, the odds ratio for the development of new onset hypertension
associated was 2.89 (95% CI 1.46 > 5.64 for AHI >15 versus 0; Peppard et al., 2000).
However, the interpretations of these epidemiologic studies in relation to Asian
populations have several limitations. First, the OSA studies conducted in the past have
largely described the prevalence of OSA and OSA’s association to hypertension
predominantly among White populations. Second, the interpretation of data linking OSA
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to hypertension should be construed cautiously as minority populations often have
additional risk factors. Third, limited studies in the literature have been conducted that
have specifically investigated racial variations in OSA as an independent risk factor for
hypertension.
Given the significant impact of OSA on cardiovascular morbidity and mortality,
identification of OSA as an independent risk factor for hypertension among the diverse
susceptible Asian subgroups may lead to physician improvements in the diagnosis,
treatment, and control of these diseases. Additionally, the results generated from this
research would lead to the creation of larger epidemiological studies cross sectional
studies involving this vulnerable population.
Statement of the Problem
Obstructive sleep apnea is a major public health issue, with 2-6% of the
population experiencing severe obstructive sleep apnea (Cantolla et al., 2009; Punjabi,
2008; Vozoris, 2012). The current literature indicates that the repeated arousals and
intermittent hypoxemia associated with obstructive sleep apnea are principal in the
pathogenesis of hypertension (Guillot et al., 2013; Mohsenin et al., 2009; Ryan et al.,
2013). The risk of hypertension intensifies with increasing severity of obstructive sleep
apnea even after adjusting for risk factors like obesity and age (Duran-Cantolla et al.,
2009; Peppard et al., 2000; Sforza & Roche, 2012). There are no published scientific
reports on the general prevalence of OSA among Asians. Hui et al., (2006) and Kim et
al., (2004) estimated that the OSA prevalence rate among Asians was 4%. In a recent
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systematic review of the literature, Mirrakhimov et al. (2013) found that among 47,957
Asian subjects, OSA prevalence were estimated to be about 3.7% to 97.3%. This
analysis also showed that the risk factors associated with OSA were male gender, older
age, higher BMI, higher waist-to-hip ratio, greater neck circumference, arterial
hypertension, smoking, snoring, and daytime sleepiness (Mirrakhimov et al., 2013, pp.910).
However, the data are conflicting for these ethnic groups (i.e., Asians; (Genta et
al., 2008; Ip et al., 2001; Kawaguchi et al., 2011). The accumulated findings from large
scale studies of sleep-diagnosed OSA patients, random cohorts of the general population,
case-controlled, and intervention studies found no consistent evidence of obesity and
gender differences in the prevalence of obstructive sleep apnea with hypertension among
Asians (Genta et al., 2008; Ip et al., 2001; Mirrahkimov et al., 2013; Villanueva et al.,
2005).
OSA is an independent risk factor for hypertension (Bixler et al., 2000;
Kasiakogias et al., 2013; Marin et al., 2012; Nieto et al.,2000; Tsioufis et al., 2011;
Young et al., 2000). There are ethnic differences in the prevalence and severity of OSA
(Villanueva et al., 2005). Craniofacial features seem to play a role in the differences in
prevalence and severity among Asians (Duran et al., 2001).
Santa Clara County has 1.8 million residents, among whom 33.7% are Asians,
(U.S. Census Data, 2012). Health disparities exist among Asians in this county, with
certain subgroups experiencing higher prevalence of risk factors. There is a significant
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association of these two diseases in terms of cardiovascular morbidity and mortality. In
order to understand the burden of these diseases, there is a need to understand what the
prevalence of OSA and hypertension among Asians is. Hence, the purpose of the study
was to address this gap and to determine the role of other risk factors, such as age,
gender, smoking, body mass index (BMI), Mallampati score (MS), Epworth Sleepiness
Scale (ESS), and Apnea-Hypopnea Index (AHI) that influence the prevalence rate of
OSA and its association with hypertension among middle aged Asians residing in San
Jose, CA.
Purpose of the Study
The main purpose of this quantitative cross-sectional study was to determine: (a)
the prevalence rate of OSA among middle-aged Asian patients (Chinese, Filipino,
Vietnamese, Asian Indians, Korean, Taiwanese, Japanese, and Singaporean) in San Jose,
CA.; (b) the association between OSA and hypertension; and (c) the association of other
risk factors: age, gender, smoking, body mass index (BMI); Mallampati score (MS), the
Epworth Sleepiness Scale (ESS) and Apnea-Hypopnea Index (AHI) with hypertension as
the outcome.
Research Questions and Hypotheses
The overarching research question concerned the association of OSA and other
risk factors as related to hypertension among middle-aged (40-60+ years old) Asians
living in San Jose, CA. To answer the above research question, the following
subquestions were examined.
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Research Question 1. What was the association between OSA and hypertension
among a sample of middle-aged Asians living in San Jose, CA?
Null Hypothesis 1. There was no association between OSA and hypertension
among a sample of middle-aged Asians living in San Jose, CA.
Alternative Hypothesis 1. There was an association between OSA and
hypertension among a sample of middle-aged Asians living in San Jose, CA.
Research Question 2. What was the association between age and hypertension
among a sample of middle aged-Asians living in San Jose, CA?
Null Hypothesis 2. There was no association between age and hypertension
among a sample of middle-aged Asians living in San Jose, CA.
Alternative Hypothesis 2. There was an association between age and
hypertension among a sample of middle-aged Asians living in San Jose, CA.
Research Question 3. What was the association between gender and hypertension
among a sample of middle-aged Asians living in San Jose, CA?
Null Hypothesis 3. There was no association between gender and hypertension
among a sample of middle-aged Asians living in San Jose, CA.
Alternative Hypothesis 3. There was an association between gender and
hypertension among a sample of middle-aged Asians living in San Jose, CA.
Research Question 4. What was the association between smoking status and
hypertension among a sample of middle-aged Asians living in San Jose, CA?
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Null Hypothesis 4. There was no association between smoking status and
hypertension among a sample of middle-aged Asians living in San Jose, CA.
Alternative Hypothesis 4. There was an association between smoking status and
hypertension among a sample of middle-aged Asians living in San Jose, CA.
Research Question 5. What was the association between body mass index (BMI)
and hypertension among a sample of middle-aged Asians living in San Jose, CA?
Null Hypothesis 5. There was no association between body mass index (BMI)
and hypertension among a sample of middle-aged Asians living in San Jose, CA.
Alternative Hypothesis 5. There was an association between body mass index
(BMI) and hypertension among a sample of middle-aged Asians living in San Jose, CA.
Research Question 6. What was the association between Mallampati score (MS)
and hypertension among a sample of middle-aged Asians living in San Jose, CA?
Null Hypothesis 6. There was no association between Mallampati score (MS) and
hypertension among a sample of middle-aged Asians living in San Jose, CA.
Alternative Hypothesis 6. There was an association between Mallampati score
(MS) and hypertension among a sample of middle-aged Asians living in San Jose, CA.
Research Question 7. What was the association between the Epworth Sleepiness
Scale (ESS) and hypertension among a sample of middle-aged Asians living in San Jose,
CA?
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Null Hypothesis 7. There was no association between the Epworth Sleepiness
Scale (ESS) and hypertension among a sample of middle-aged Asians living in San Jose,
CA.
Alternative Hypothesis 7. There was an association between the Epworth
Sleepiness Scale (ESS) and hypertension among a sample of middle-aged Asians living
in San Jose, CA.
Research Question 8. What was the association between the Apnea-Hypopnea
Index (AHI) and hypertension among a sample of middle-aged Asians living in San Jose,
CA?
Null Hypothesis 8. There was no association between the Apnea-Hypopnea Index
(AHI) and hypertension among a sample of middle-aged Asians living in San Jose, CA.
Alternative Hypothesis 8. There was an association between the ApneaHypopnea Index (AHI) and hypertension among a sample of middle-aged Asians living
in San Jose, CA.
The analysis determined the association between OSA, age, gender, smoking
status, body mass index, Mallampati score, the Epworth Sleepiness Scale, and ApneaHypopnea Index to hypertension. Means, standard deviation, and frequency of
distribution were calculated for continuous independent variables such as age, gender,
ethnicity, sex, and BMI.
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Theoretical Foundation
The theoretical guide for this study was the sufficient component causes model.
This model, which, emerged in the epidemiological literature in 1976, described the
many contributing determinants, and risk factors that make up the multifactorial
etiologies involved in the association between OSA, and hypertension among middleaged Asian patients.
The sufficient component causes model, pioneered by Rothman (1976), is an
epidemiological model that defines a sufficient cause as “a complete causal mechanism”
that eventually leads to the development of a disease (Flanders et al., 2006; VanderWeele
et al., 2006). This model considers the development of a disease either through a
complete causal mechanism, or through a minimum set of conditions or factors, that, if
present in a given individual, will be sufficient for the outcome to ensue (Rothman et al.,
2008).
According to the major proponents of this model, health conditions are outcomes
of complex component interrelationships of various predisposing factors that must be
present or have occurred for the disease to manifest (Rothman et al., 2008, pp. 6-8). The
sufficient cause component model seeks to identify the possible set of conditions critical
to the development of illness by recognizing the constellation of component causes of
conditions, factors causing the condition(s), and factors that act in unification to cause the
condition (Rothman et al., 2008, pp. 7-8). The sufficient component cause model is
characterized by a number of features; for instance, a cause not single but consists of a
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minimal set of conditions or events, each component in a sufficient cause is called a
component cause, and there is no need to identify all of the component causes to prevent
the disease outcome (Aschengrau & Seage, 2008). This component cause together
constitute a sufficient cause for the outcome in question. In order to fully understand all
the risk factors, exposure, and contributory causes of the disease, the model requires
complete understanding or investigation of the diseases (Timmreck, 2006, p. 209).
The sufficient component cause theory guided this study and made it possible to
describe the association between OSA and hypertension among middle-aged Asians in
the United States. Studies have shown that the independent association of OSA to
hypertension is affected by the increased sympathetic activity in response to hypoxemia
and hypercapnia that lead to chemo reflex activation, which increase the peripheral
vascular tone (Phillips & Somers, 2003). This sympathetic response continues even into
daytime normoxia (Phillips & Somers, 2003, p. 381). Chemoreceptors, both peripheral
and central, are inhibited, leading to decreased ability to breathe (Sadikot, 2008). The
subsequent hypoxemia can stimulate the augmented production of many circulating
vasoconstrictors that raise blood pressure (Phillips & Somers, 2003, p. 382). The
consistent cycles of increased sympathetic stimulation, renin-angiotensin system,
endothelial dysfunction, cerebral blood flow alterations, oxidative stress, and systemic
inflammation also contribute to an increase in heart rate and blood pressure. The
presence of risk factors (e.g., obesity; craniofacial morphology) in sleep apnea likely
indicates an increased susceptibility to hypertension (Phillips & Somers, 2003, p. 383).
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The key constructs of this model supported the belief that component causes or
risk factors (e.g., body mass index (BMI), Mallampati score (MS), Epworth Sleepiness
Scale (ESS), and apnea-hypopnea index (AHI) together constitute a sufficient cause
model for the OSA-hypertension association. The table below shows how these risk
factors are associated with certain causes of OSA as an independent predictor of
hypertension as guided by the sufficient component cause theory.
Table 1
OSA Risk Factors as Guided by the Sufficient Component Cause Theory
Causes
Sympathetic stimulation

Risk factors

Measurement

Apnea/and/ or hypopnea

AHI index/Epworth Sleepiness Scale

Renin-angiotensin system

Age, smoking

Systolic and diastolic measurement

Endothelial dysfunction/systemic
inflammation
Oxidative stress

Obesity

BMI

Cerebral blood flow alterations

Craniofacial features, gender

Mallampati score

Note Adapted from “Epidemiology and The Web of Causation: Has Anyone Seen The
Spider? by N. Krieger, 1994. Social Science Medicine, 39(7), pp 887-903.
Detailed discussion of the model will be discussed in the next chapter.
Nature of the Study
I employed a quantitative cross-sectional study to determine the relationship
between OSA as an independent variable and hypertension as the outcome among
middle-aged Asian patients. The advantage of using this type of study was that it allowed
me to examine the associations between variables within a short period of time based on
biological plausibility and past research (Newman et al., 2007). The main variables that
the study assessed were obstructive sleep apnea, as the independent variable and
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hypertension as the dependent variable. Other risk factors including age, gender,
smoking, OSA severity (measured by apnea-hypopnea index [AHI]), body mass index
(BMI), daytime sleepiness (measured by Epworth Sleepiness Scale [ESS]), and
craniofacial characteristics (measured by Mallampati score [MS] were assessed for their
role in the development of hypertension as the outcome in association with OSA using
ANOVA.
Three sleep study clinics were used to assess the participants who partook in an
overnight polysomnography in a real life sleep clinic in San Jose, CA. The study
variables and other demographical information including age, sex, history of smoking, etc
were collected and analyzed using paper and electronic medical records.
Definition of Terms
Apnea is the absence of airflow for 10 seconds in the presence of continued
respiratory effort (Hahn & Somers, 2007, p. 943).
Apnea-hypopnea index (AHI) is the total number of apneas and hypopneas
divided by the total number of hours of sleep (Banno et al., 2007, p.402).
Asians refer to the group of people living in Asia. The Behavioral Risk Factor and
Surveillance system categorizes this group into seven groups; namely, Asian Indian,
Filipino, Chinese, Vietnamese, Korean, Japanese and other Asians (Palanaippan et al.,
2010).
Body mass index is a reliable measure to determine body fat for individuals. It is
calculated based on a person’s weight and height.
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Hypertension also called high blood pressure, is based on the measured force of
blood against the walls of the arteries as the heart pumps blood to the body (Victor,
2011).
Hypopnea is a reduction in airflow ≥ 50% for 10 seconds with 4% drop in arousal
and saturation (Hahn & Somers, 2007, p. 943). Hypopnea is clinically significant when
associated with an oxyhemoglobin desaturation event or with a central nervous system
arousal characterized by EEG changes or alpha activity (Hirskowitz & Kryger, 2005).
Epworth Sleepiness Scale is a scale to measure daytime sleepiness by using a
questionnaire. A score of 10 or more is considered sleepy.
Mallampati score is a grading scale to assess the tonsil and visibility of the
tonsillar fossa. Class 1 shows that the entire tonsil is visible, Class 2 shows that only half
of the tonsil fossa is visible, Class 3 shows clear visibility of the soft and hard palate and
Class 4 shows only the hard palate (Mallampati et al., 1985).
Obstructive sleep apnea syndrome (OSAS) is clinically defined as AHI ≥ 5 per
hour with symptoms or more than 15 without symptoms (Hahn & Somers, 2007, p. 943).
This condition is characterized by breathing cessation caused by obstruction of the upper
airway (Hirskowitz & Kryger, 2005).
Oxygen desaturation index (ODI) is the number of oxyhemoglobin desaturation
events per hour of sleep (Hirskowitz & Kryger, 2005).
Polysomnography (PSG) is the method used to consistently measure nasal
pressure, oxygen saturation, electroencephalogram, electro-oculogram, chin and lower
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extremity electrocardiogram, chest, and abdomen plethysmography (Hahn & Somers,
2007, p. 943).
Assumptions
The basic assumption of this study was that it was conducted among study
subjects who had consented to participate voluntarily. Due to the voluntary nature of this
study, it is hoped that the results were not influenced by a high degree of bias. The study
used secondary data obtained from sleep clinics in San Jose, CA. Walden University
Institutional Review Board with approval number 03-25-14-0153639 approved the use of
secondary data from three sleep study clinics in San Jose, CA. The adoption of
secondary data presents an opportunity to develop primary data in future research. It is
also assumed that the sleep metrics used, including AHI, polysomnograms, and other
metrics, were suitable to measure the study variables.
The secondary data i.e., electronic medical records system used in this study
represented real world data that reflected fairly accurately actual physician practice
compared to observational data (Dean et al., 2009). It was assumed that the respondents
were accurately diagnosed according to symptoms and clinical presentations. It was also
assumed that participants’ gender did not significantly affect physicians and other allied
health professionals diagnosis of the conditions.
I also assumed that craniofacial features influenced the relationship between OSA
and hypertension. The craniofacial abnormality subjects the pharynx to be a risk of
airway closure independent of soft tissue influences. The Mallampati Scoring System as
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marker for craniofacial abnormality was scored typically by physicians who were
assumed to be able to identify the four anatomical landmarks in the oropharyngeal region.
Scope and Delimitations
This study was about the prevalence rate of OSA as an independent variable in
association with hypertension as an outcome among middle aged Asians. Due to the
large number of potential participants in the study population, the study only focused on a
sample of 462 Asians in three sleep study clinics located in San Jose, CA during the
period from January 1, 2008 to December 31, 2011. The generalizability of this
epidemiological study may be limited to certain Asian Americans living in San Jose, CA
and may not be representative of the United States, as a whole. It is known that diseases,
regardless of etiology, are affected by multifactorial causes. As the study focused only
on OSA and hypertension as the outcome, the study is most relevant in this particular
area. The data and results of the study were derived from electronic and paper medical
records, in which study participation among the subjects and the medical practitioner
were assumed to be voluntary. Thus, the study was subjected to inherent limitations of
such methods, including biases related to patient population, selection and reporting. The
potential biases related to patient population, selection, and reporting were reduced by
randomly sampling patient population within three sleep clinics used in this study. The
potential bias was also eliminated by obtaining the appropriate number of patients to
power the study, judiciously designing the study, guaranteeing that sample methods were

17
reliable, and employing procedures using standardized methods to accurately measure the
data collected (Peat & Mellis, 2002).
Limitations
A limitation of this study was that the sample was drawn from Santa Clara County
only. This affects the generalizability of the study to the other counties. In order to
address this issue, the study used the correct t-value for alpha which is 0.05. The study
employed data obtained from electronic medical records (EMR) and paper medical
records which were basically designed for clinical care and not research. EMR provide
the researchers with easy access to patient data, large cohorts, patient-level diagnoses,
treatment data, and billing, and laboratory information. However, limitations in the use
of EMR include information entered being decided by the provider, information entered
in free text, scanned images, flexibility in terminology, a minimal number of required
fields, and important data irrelevant to clinical care is missing (Terry et al., 2010).
Another limitation of the use of secondary data is the lack of clinical detail (Gallin &
Ognibene, 2012). This is especially true because certain EMR data sets will contain
clinical data relevant to physician payments (Gallin & Ognibene, 2012, p. 375). Another
limitation of the study was the inability of the researcher to provide the temporal
sequence of the exposure and the outcome (Ho et al., 2008). In order to assure that the
tools for the analysis and data generated were valid and reliable, I checked for bias, and
cross checked the data looking at both paper and electronic records if both were available
(Babbie, 2010). Validity issues in this study might stem from bias in data collection,
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subject selection, and inadequate procedures (Creswell, 2009). In order to address these
issues, I validated the codes used by the practitioners by confirming with the current
International Classification of Diseases Manual, randomly sampling patients in the study
sleep study clinics chosen for the study, and setting inclusion and exclusion criteria for
patient selection. To validate the research findings, I looked at existing literature to
confirm which specific variables would throw light on the relationship between the
variables and covariables (to determine the accuracy of findings), and construct validity
(if the theoretical model applied well in this study) (Creswell, 2009, pp. 149- 190).
The limitations associated with this data analysis also included variation in
software platforms used by the clinics for their EMR systems, medical terminology,
clinical data, (i.e., laboratory results), and units of measurement (Dean et al., 2009). In
order to address these issues, the researcher ensured that standardized coding practices
were adopted at each clinic, similar medical terminologies were used; and laboratory
results were reported in the same units of measurement (Dean et al., 2009, p. 613).
Significance
There are very limited published scientific data on the general prevalence of OSA
among Asians. This study uniquely addressed an important public health issue among a
segment of the population that has significantly grown in number in the San Jose, CA
area for the last few years. This study was able to provide much needed data on the
prevalence of OSA and the associated risk factors between OSA and hypertension. The
valuable insights that may be acquired from this study could pave the way for additional
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scientific pursuits that could lead to better understanding of OSA and hypertension
among middle aged Asians.
This study also adds to the epidemiologic understanding of OSA as the
independent variable and hypertension as an outcome among middle-aged Asians in San
Jose, CA. OSA-hypertension research studies conducted among high risk Asian groups
can generate valuable public health insight into the disease and its risk factors. This is
critically important especially when studies involving OSA do not adequately synthesize
or provide clarity regarding the health differences among Asian Americans. Because
there are still a great number of underdiagnosed and undertreated Asian patients in San
Jose, CA, the results generated from this research can lead to successful identification,
screening, treatment, and management of OSA and hypertension especially among highrisks middle-aged Asians, thus creating positive social change for those individuals and
their families and community. This study can also foster social change by empowering
members this ethnic group to advocate for themselves and collectively challenge service
providers, government agencies, and other institutions to ensure equal access to
healthcare, and available services. Additionally, this study may create positive social
change by fostering improvements in health outcomes and the lives of Asians who have
been suffering from OSA and hypertension for a long time.
Summary
The prevalence of OSA and hypertension in the United States continues to rise.
The various structural and functional cardiac dysfunctions associated with OSA have
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important pathologic consequences to the development of hypertension. Numerous
observational and epidemiologic studies have been designed to better understand the
association of OSA and hypertension and the consequences they have for CVD among
Caucasian patients. OSA data among Asians are very limited.
Hypertension outcomes associated with OSA have been measured by
polysomnography specifically using the Apnea-Hypopnea Index (AHI) as a common
metric. Body mass indexes (BMI), Mallampati scores (MS), and the Epworth Sleepiness
Scale (ESS) are also common metrics used in OSA studies.
Research efforts in the field of sleep apnea have provided intense and consistent
results linking OSA to hypertension. The epidemiologic data from various human
populations that are consistent with the mechanistic theory that supported the study are
summarized in the next chapter.
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Chapter 2: Literature Review
The literature review provided the basis for the need to examine the prevalence
rate of OSA and its association to hypertension among middle aged Asian patients. In the
last three decades, investigations have shown significant linkages between OSA and
hypertension, as well as their important implications on long term effects on
cardiovascular morbidity and mortality. Mechanistic, animal, human interventional and
epidemiological studies have revealed that systematic changes in blood pressure in OSA
together with the presence of significant confounders are major contributors to the
development of hypertension. Although this association between OSA and hypertension
had been reported in the literature, systematic investigations to address the question of
whether similar associations are seen among Asians have rarely occurred. The unique
craniofacial anatomic features among Asians may be the delineating difference (e.g.,
retrognathia) that can predispose Asians to develop OSA leading to hypertension. The
theoretical foundation that guided this dissertation was the sufficient component cause
model. This sufficient component cause model may be used to describe the association
of OSA and hypertension as these diseases are highly associated with a number of
significant risk factors (Dopp et al., 2007; Stehbens, 1985). The associated risk factors
are significantly associated with the development of the disease, and if these risk factors
are modified by intervention, it reduces the occurrence of the disease. The complete
airway obstruction experienced during sleep leads to apnea or cessation of breathing,
whereas the experienced caused by partial airway obstruction leads to hypopnea and
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elevated PCO2, (Banno & Kryger, 2007, p. 401). A recent review of the literature
showed that this theoretical construct provided a clear view of how these various risk
factors work together to impact the OSA and the development of hypertension among
middle-aged patients (Bixler et al., 2001; Bixler et al., 1998; Duran et al., 2001, Ip et al.,
2001, Peppard et al., 2000; Young et al., 2002).
The empirical basis of this research is supported by peer-reviewed journals. The
search for relevant articles to support the aforementioned evidence was made using
medical search terms, subject headings, reference lists, key words and “related articles”
links using MEDLINE, PUBMED, Medscape, CDC, NIH, Science, and Walden
University library databases. The search terms to obtain these scientific articles included
obstructive sleep apnea, hypertension, sufficient component cause model, sympathetic
activation, apnea cardiovascular adverse effects, age, craniofacial characteristics, AHI
index, obesity, ethnicity sleep apnea, multicausation, hypertension risk factors,
hypertension trends, OSA risk factors, Asians, and Asian Americans. Sources to support
this dissertation were obtained either in digital format or as traditional printed versions of
scientific articles. The search of these articles was limited to those published between
1995 and 2012 and written in English. The articles chosen were from epidemiologic
research. This dissertation was also supported with multiple books to provide years of
scientific research on obstructive sleep apnea and hypertension.
This chapter provided a review of OSA, hypertension, relevant theoretical
constructs, and the pathophysiologic evidence to support OSA’s linkage to hypertension.
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The chapter also provides systemic epidemiologic review of the literature to support the
contributory role of OSA to hypertension. This chapter also contains a discussion of the
current challenges of the outcomes of these research areas.
Obstructive Sleep Apnea: Introduction
The majority of cases of hypertension have unknown causes, whether
hypertension could be considered primary or essential (Kaplan, 2011). Additionally, the
severity of hypertension is largely determined by specific demographic features (age, sex,
race, etc.), the magnitude of vascular damage from high blood pressure, and the presence
of other risk factors (Kaplan, 2011, p. 15). The complicated etiology and
pathophysiology of hypertension emanate from the heterogeneous nature of the disease
(Izzo & Black, 2003). Multiplicative factors modulate blood pressure control (Heilperm,
2008). Epidemiologic studies have revealed that OSA in combination with other CV risk
factors is associated with hypertension, which predispose patients to the risk of both
cerebrovascular and ischemic heart disease (U.S Department of Health and Human
Services, 2004, p. 1). The effective management of hypertension has been associated
with considerable improvements in aged-adjusted death rates from stroke and heart
disease irrespective of gender, age, race or socioeconomic status (U.S. Department of
Health and Human, 2004, p. 1). However, follow-up studies conducted with multiple
populations have indicated that morbidity and mortality rates are higher among patients
receiving antihypertensive drug treatments compared to untreated patients with similar
levels of blood pressure (Ben-Dov et al., 2007). These studies indicate that modest CVD
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improvements could be due to: partial reduction in blood pressure, irreversible organ
damage from hypertension, and other risk factors not properly addressed (Kaplan, 2011,
p. 8). The strategic management of hypertension comes with knowledge of evaluation of
other important risk factors. Clustering of this hypertension associated risk factors occurs
approximately 50% of the time (Caceres et al., 2012). Identification of these associated
risk factors can lessen the degree of coronary events, stroke, peripheral disease, or heart
failure (Kaplan, 2011, p. 10). The numerous pathological mechanisms involve with OSA
increase the risk of hypertension (Calhoun & Harding, 2010). Peppard et al., (2001)
showed that even after adjustment of known risk factors for hypertension, there was a
twofold risk increase for patients with AHI of 5-15/ hour and threefold increase for
patients with AHI > 15 (Peppard et al., 2000, p. 1378).
Definitions: Obstructive Sleep Apnea and Hypertension
Diagnosis of hypertension, defined as blood pressure of 140mmHg/80 mmHg, is
often challenge by the fact that considerable variability in measurements occurs (Kaplan,
2011). Sources of variation include inappropriate equipment, inaccurate reading,
incorrect positioning of the arm, and observer bias (Kaplan, 2011, p. 25). Chang et al.,
(2002) reported 64-82% residual variability with systolic and diastolic measurements
from inaccuracy of the device. In order to establish accuracy for in home, in office or in
clinical studies, patients are advised to prevent marked changes induced by activity and
position, keep a diary of activities, use computer-assisted diaries, use electronic monitors
and obtain average values within the 24 hours (Kaplan, 2011, p. 39).
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It is important to establish the clinical definition of OSA in order to fully
comprehend the key differences between the sensitivity, specificity and predictive value
of the various diagnostic techniques used in various studies (Frederick & George, 1999,
p. 356). Guilleminault & Dement (1976) defined OSA as cessation of airflow for 10
seconds with 30 apneic events observed in both REM and NREM sleep observed during
seven hours of sleep study (Frederick & George, 1999, p. 357). The diagnosis of OSA is
confirmed by Apnea-Hypopnea Index (AHI) or Respiratory Disturbance Index (RDI) ≥ 5
events /hour during a polysomnography with monitored respiratory parameters (Kushida,
et al., 1997). OSA is a chronic condition involving a characteristic closure of the airway
at the supraglottic area (Mansfield & Naughton, 2005). This effect converges at the
apnea termination, which causes the recurrent brief arousals throughout the night
(Mansfield & Naughton, 2005, p. S2). OSAs are associated with variable drop in arterial
oxygen saturation (SAO2) of various intensities (Mansfield & Naughton, 2005, p. S2).
The International Classification of Sleep Disorders, 2nd edition, categorically diagnoses
OSA as follows:
A. At least one of the following:
•

complaints of unintentional sleep episodes during wakefulness, daytime
sleepiness, unrefreshing sleep, fatigue or insomnia;

•

awakenings with breath holding, gasping, or choking;

•

bed partner reports loud snoring, and or breathing interruptions during the
patient’s sleep.
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B.

Polysomnography with the following results:

•

scoreable respiratory events (apneas + hypopneas + Respiratory Effort –
Related Arousals (RERA)/hr. of sleep ≥ 5/hr.);

•

evidence of respiratory effort during all or a portion of each respiratory
event (In the case of RERAs, respiratory effort is best detected by
esophageal manometry); or

C.

Polysomnography with the following:

•

score able respiratory events (apneas+hypopneas+RERAs)/hr. of sleep ≥
15/hr;

•

evidence of respiratory effort during all or a portion of each respiratory
event;

D. The disorder is not better explained by another current sleep disorder, medical
or neurologic disorder, medication use, or substance use disorder (American
Academy of Sleep Medicine, 2001).
The American Academy of Sleep Medicine defined OSA based on RERAs but
not RDI (number of respiratory events per hour of monitoring time). The majority of
sleep studies use RDI instead of RERA. However, most of the literature do use the OSA
diagnostic criteria of AHI ≥ 5/hr. with symptoms or AHI ≥ 15/hr. with or without
symptoms (Bradley & Floras, 2009). The ICD definitions do not include partial
obstruction or complete obstruction to diagnose OSA.
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The Practice Parameters of the American Academy of Sleep Medicine established
a consensus statement in 1997 the evidence based recommendations for the diagnosis and
management of OSA. Based on this evidence based guideline, the diagnosis of OSA
must be established with sleep history, physical examination, and standard sleep testing
(in laboratory polysomnography (PSG), or home testing with portable monitors (PM;
Epstein et al., p. 266, 2009). PSG is routine test for clinical diagnosis and indicated for
patients with high pretest likelihood of moderate to severe OSA (i.e., obese, heart failure,
coronary artery disease, history of transient ischemic stroke, or significant arrhythmias
(Epstein et al., 2009, p. 266). Diagnosis should be obtained in one of three settings: 1.as
routine health maintenance evaluation; 2. as part of evaluation for patients with
symptoms of OSA; and 3. as part of comprehensive evaluation of patients’ high risk for
OSA (Epstein et al., 2009, p. 264). The important features that are clinically relevant in
the diagnosis for OSA includes increased neck circumference (>17 inches for men and 16
inches for women), body mass index (BMI > 30 kg/m2), modified Mallampati score of
three or four, presence of retrognathia, lateral peritonsillar narrowing, macroglossia,
tonsillar hypertrophy, elongated/enlarged uvula, high arched/narrow hard palate, nasal
abnormalities, and/or over-jet (Epstein et. al., 2009, p. 266).
OSA and Hypertension: Theoretical Constructs
Rothman (1976) recognizing that the occurrences of certain diseases were caused
by multiple causes, in which no single factor can produce the disease itself, proposed a
model that he termed a “sufficient component cause model”. According to Rothman
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(1976) a “cause” is a state of nature, act, or event that leads, or allows either by itself, or
combination with other causes, a succession of events that will lead to an “effect” (Rao &
Enterline, 1983). The “sufficient component cause model” represented the cause that
would be estimative to produce the outcome as “sufficient” (Rao & Entreline, 1983, p.
268). Thus, Rothman (1976) believed that a sufficient cause is an amalgamation of
condition that consequently would lead to the outcome in consideration (Rao & Enterline,
1983, p. 267). According to this model, a number of component causes make up the
sufficient cause, which will operate sufficiently enough under various sets of component
causes to act as “sufficient cause” (Martin, 2008). In other words, the sufficient
component cause model embodies biologic relations in the form of involvement of
factors in a sufficient cause (Vanderweele, 2009).
The term “causation” refers to the relationship between at the least two entities:
the agent and the disease (Vineis & Kriebel, 2006). The sufficient component cause
theory does not imply that there is a specific cause for a given disease in a given
individual but rather the disease is smartly intertwined with multiple intersections which
determines the association between given exposure and frequency of disease in a given
population (Vineis & Kriebel, 2006). The associations can indicate that the exposure
might cause the disease or the exposures are associated with difference in “risk factors”
(Krieger, 1994).
According to this model, sufficient cause refers to “a set of minimal conditions
and events” not necessarily gratuitous, that leads to the production of the disease (Allard
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& Boivin, 1993). The components of each the conditions which are part of the sufficient
cause, which will be called a “component” of the cause (Allard & Boivin, 1993, p. 37).
The assemblage of the components of the disease would then lead to the development of
the disease (Allard & Boivin, 1993, p. 37). Sufficient causes are basically disease
producing process, in which the accumulation of the components would be sufficient
enough for the expression of the disease (Allard & Boivin, 1993, p. 37).
Rothman (1976) further refined the sufficient component cause theory to take into
account confounding and effect modification to pay attention to the relationships between
“necessary and component causes”. Rothman developed the sufficient component cause
model which incorporated the “sufficient causal complexes, with five component causes”
later termed as “causal pie model”. By bringing attention to these factors, Rothman was
able to show that the strength of the association between the component cause and
outcome depended on the prevalence of other components that influenced the specified
change (Krieger, 1994, p. 891). Additionally, this concept explained that diseases were
caused by mixtures of conditions or multiple conditions that together contributed to the
development of the disease, and that various combinations of component causes can
produce the disease; and that the multiple causes need not include any component cause
in common (Labarthe, 2011, p. 541).
Aschengrau and Seage (2003) outlined that the basic features of the sufficient
component cause model are as follows:
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1.

There is no single cause for the disease but a minimal set of

conditions or events that would lead to the development of the outcome.
2.

Each of the component causes is important in the sufficient

component cause model; however, it is not necessary to identify all of the
component causes in order to avert the disease.
3.

There could be a number of sufficient cause for a given disease or

outcome.
4.

A component cause that must be existent in every sufficient cause

of a given outcome is termed “necessary cause”.
5.

The biologic occurrence of the outcome must parallel with the

completion of a sufficient cause.
6.

The components of the sufficient cause can act at different times

and not necessarily concurrently.
The sufficient component cause model can help explain the theoretical structure
of sufficient causes for OSA and hypertension. A sufficient cause can be interpreted in
this case as if the risk factor for hypertension is present, then the presence of that risk
factor, in this case OSA, leads to the increase risk of the disease. Additionally, the
relationship between OSA and hypertension is an example of a chronic disease caused by
an array of sources and risk factors. The association between hypertension and OSA is
multifactorial, with a number of unique overlapping causal mechanisms (Punjabi, 2008).
The source of interaction between component causes in the sufficient component cause
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model as proposed by Rothman (1976) is the combined involvement of the component
causes in a sufficient cause (Rao & Enterline, 1983). This theoretical construct supports
the idea that OSA involves grouping of one or more of the sufficient causes and the factor
that is part of more than one sufficient cause (Martin, 2008). The components of a
sufficient cause can be simultaneous, or can be represented by a chain of events, in which
one of the components can lead to another (Martin, 2008, p. 274). The physiologic
changes allied with OSA bring a plethora of various changes that contributes to the
etiopathogenic mechanism of hypertension, of which a single component cause may be
insufficient to root the given disease (Cantolla-Duran et al., 2009). Studies have shown
that the multitude of events and sources involved with OSA that lead to the changes in
hypertension physiology are; the negative intrathoracic pressure, sympathetic activation,
effects of hypoxia, oxidative stress, vascular endothelial dysfunction, metabolic, and
dysregulation and inflammation.
Negative Intrathoracic Pressure
In OSA, the negative intrathoracic pressures generated are from the inspiration
against a closed upper airway (Adegunsoye & Ramachandran, 2012). This results to
negative intrathoracic pressure as low as -80cm H20, which affects both left and right
ventricular function (Adegunsoye & Ramachandran, 2012, p. 4). Numerous studies
showed that negative intrathoracic pressure lead to adverse consequence to left
ventricular function thru elevating left ventricular transmural pressures and increasing
afterload (Buda et al., 1979; Virolainen et al., 1995).
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Sympathetic Activation and Hypoxia
In OSA, the arterial PCO2 is increased with the rise in arterial PO2 and SaO2
decrease which permitted the rise of the chemical drives (Cheng et al., 2010). As the
total ventilator drive is greater than the arousal threshold, the arousal is generated to
allow opening of the upper airway to resume airflow (Cheng et al., 2010, p. 6). The
arousal threshold is linearly related to SWA. The higher the threshold, the higher the
SWA, and closer to one during NREM sleep, while when the threshold is lower, the
lower SWA or closer to zero during REM sleep (Berry & Gleeson, 1997). During regular
sleep cycles, cardiorespiratory homeostasis is achieved through the coordination of both
the respiratory and cardiovascular system (Khoo et al., 2011). The cardiorespiratory
control mechanisms are direct consequences of variations in brain states that typically
transpired during alternating cycles of NREM and REM sleep (Verrier et al., 2005). The
CNS activations dynamically fluctuate to affect heart rate, blood flow, and ventilation
(Verrier et al., 2005, p. 193). REM-induced surges facilitate the activation of
sympathetic and parasympathetic nerve activity causing the surges and pauses in heart
rhythm (Verrier et al., 2005, p. 193). In NREM stage, the coupling of the respiratory
activity and cardiorespiratory centers resulted to the normalization of respiratory sinus
arrhythmia, (Verrier et al., 2005, p. 193). NREM stage allowed stable sympathetic
activity (Verrier, et al., 2005, p. 193). The cardiorespiratory homeostasis achieved during
sleep is often altered among OSA patients. The mitigating effects of repeated arousals
and intermittent hypoxia characteristic of OSA lead to restructuring of the control
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mechanisms (Verrier et al., 2005, p. 194). These types of changes lead to interference in
compensatory mechanisms to assist blood pressure management and remove forebrain
influences on hypotension or hypertension (Verrier et al., 2005, p. 194).
Hypoxia is also an important intermediate mechanism that increased the
development of hypertension among OSA patients (Leung et al., 2012). These
pathological effects acutely lead to hemodynamic and autonomic changes that alternate
between the apneic and ventilator phases (Leung et al., 2012, p. 221). Heart rate and
blood pressure increase happens five to seven seconds after the apneic termination
(Leung et al., 2012, p. 221). The OSA related sleep arousal accordingly leads to peak in
respiration with the pits of SaO2 (Leung et al., 2012, p. 221). The hypoxia experienced
during OSA contributes to reduction in myocardial oxygen demand, depression of the
myocardial contractility, and elevation of left ventricular afterload (Leung et al., 2012, p.
221). The sympathetic activation caused the hypoxia driven events which increased heart
rate (Leung et al., 2012, p. 221). The relationship between these intermediates is shown
in the figure below.
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Apneas/Hypopneas/Respiratory
Effort-Related Arousals

Repetitive Cycles during sleep
Intermediate Mechanisms Activation
Oxidative stress
Hypoxemia-reoxygenation
Sleep fragmentation
Hypercapnia
Metabolic alterations
Sympathetic activation
Endothelial damage

Risk factors
Race
Obesity
Male sex
Age
Dyslipidemia and metabolic disorders
Alcohol and tobacco use
Craniofacial morphology
Others

Interaction

Hypertension
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Figure 1. Theory of sufficient component cause model. The sufficient component cause
model helps explain the relationship between the unique overlapping causal mechanisms
that can lead o or affect the pathophysiologic changes involved in the relationship
between OSA and hypertension. Adapted from “Obstructive sleep apnea/hypopnea and
systemic hypertension” by Cantolla et al., 2009, Sleep Medicine Reviews.13, pp.323-331

The distinctive respiratory disturbance associated with OSA is the complete
cessation of breathing that leads to apnea or partial cessation of breathing that led to
hypoventilation (Krieger, 2005). This disturbance has three pathophysiologic
consequences: 1. hypoxemia-reoxygenation leading to arterial blood gas abnormalities; 2.
consistent arousals and transformation to light sleep stages; and 3. large dips in
intrathoracic pressure (Krieger, 2005, p. 237).
All these pathologic disturbances cause increase in sympathetic neural response.
The sympathetic activation originated from the characteristic apneic events associated
with OSA which lead to escalation of breathing, high negative intrathoracic pressure,
persistent hypoxia, reoxygenation, and oscillations in autonomic activity (Krieger, 2005,
p.238). The pronounced and severe apneic events eventually impact the hemodynamic
reflex changes and sustained sympathetic activation (Krieger et al., 2005, p. 238). The
elevation in sympathetic response causes activation of vascular smooth muscle to
vasoconstriction which eventually leads to elevation of blood pressure (Fletcher et al.,
2002). These heightened sympathetic activities stimulate production of angiotensin II,
and renin in the kidneys (Fletcher et al., 2002. p. 627). The sustained sympathoexcitation
as the likely mechanism of the OSA-hypertension relationship had been observed among
OSA patients (Bao & Fletcher, 1997; Carlson et al., 1993; Waradeker et al., 1996).
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Oxidative Stress
The marked oxidative stress associated with OSA comes from the marked
decreased in arterial oxygen saturation (Adegunsoye & Ramachandran, 2011, p. 5). The
arterial oxygen desaturation causes similar effects brought about by recurrent episodes of
ischemia-reperfusion injury (Yamauchi et al., 2005). This type of injury causes damage
to the heart attributed to production of reactive oxygen species (ROS) during
reoxygenation (Yamauchi et al., 2005, p. 1674). A number of studies had shown that
oxidative stress associated with OSA, including increases in ROC production were seen
among OSA patients (Dyugovskaya et. al., 2002; Schulz et. al., 2000). Yamauchi et al.,
(2005) similarly showed that urinary 8-OHdG excretion, a marker of oxidative stress,
were higher among OSA patients.
Vascular Endothelial Dysfunction
Repetitive hypoxia associated OSA syndrome can lead to vascular endothelial
dysfunction, (Ip et al., 2004; Ip et al., 2000). This effect is caused by reduction in
endothelial nitric oxide production at the transcriptional and posttranscriptional levels as
well as the rise of reactive oxygen species (ROS; Liao, et al., 1995; McQuillan, et al.,
1994). The increased production of ROS causes oxidative stress, destabilization of eNOS
messenger RNA to limit production of cofactors necessary for NO production (Laursen et
al., 2001; Takemoto et al., 2002). The short and long term effects of this oxidative stress
lead to decline in eNOS activity thru subdual of phosphorylation (Takemoto et al., 2002,
p.57). This reduction in NO production affects OSA patients to develop vascular
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diseases, (Takemoto et al., 2002, p. 60). The repetitive arousals commonly associated
with OSA also lead to endothelial damage (Atkenson et al., 2009). The Nurses’ Health
Study involving 71, 617 female participants aged 45-65 years showed that self-reported
sleep reduction was associated with increased incidence of coronary heart disease (993
coronary events; Ayas et al., 2003). The study participants who had fewer than five, six,
or seven hours of sleep reported age adjusted relative risks of coronary heart disease of
1.82 [1.34-2.41], 1.30 [1.08-1.57], and 1.06 [0.89-1.26] 95% Cis ( Ayas et al., 2003, p.
205).
Metabolic Dysregulation
Metabolic dysregulation plays a pivotal role in the association between OSA and
various cardiovascular diseases (Butt et al., 2010). The main drivers that impact the
associated role of these factors are also driven by elevated sympathetic activity, changes
in neuroendocrine function, and release of proinflammatory cytokines (e.g. interleukin-6,
tumor necrosis factor, and adipocyte derived factors (Aurora & Punjabi, 2007). Five
observational studies that looked at patients aged 40-75 years of age with symptoms of
snoring or apneas were associated independently with increase in glucose, insulin
resistance, or increase in risk for incident diabetes (Al-Delaimy et al., 2002; Elmasry et
al., 2000; Enright et al., 1996; Grunstein et al., 1995; Jennum et al., 1993).
Inflammation
There are various markers of inflammation that posed as significant risk factors
for cardiovascular disease that are associated with OSA (Nadeem et al., 2013). These
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markers of inflammation include tumor necrosis factor alpha (TNF-), acute phase factor
C-reactive protein (CRP), interleukin 6 (IL-6), etc. (Gozal & Gozal, 2008). These
inflammatory markers acutely affect cardiac function leading to alterations in cardiac
function such as hypertension and atrial fibrillation (Almendros et al., 2011). Oxidation
of low density lipoprotein (LDL) due to endothelial injury had been observed among
hypoxic OSA patients compared to normal controls (Walli, et al., 1998). Additionally,
Carlson et al., (1993) significantly observed that among OSA patients there were more
vessel resistance compared to controls. Blunted vasodilator response in the forearm to
acetylcholine, as a measure of endothelial injury, were also more apparent among OSA
patients compared to carefully match obese subjects without OSA (Kato et al., 2000).
Studies of the Relationship Between OSA and Hypertension
OSA is an independent risk factor for the development of hypertension (National
Sleep Foundation, 2005). The association between OSA and hypertension has been
established by the scientific literature since 1908s (Santos et al., 2006). The earlier
findings were mixed and possibly flawed due to the presence of confounders (e.g.,
alcohol consumption, caffeine intake, and family history; Sadikot et al., 2008).
Subsequently, many published studies considered the flaws in earlier reports of the
association between OSA and hypertension. In the past few years, extensive evidence
obtained from cross-sectional, longitudinal and treatment studies later reported significant
associations between OSA and hypertension (Sadikot et al., 2008, p. 65). In a cross
sectional study of 147 men and women, aged 30-60 years old from the Wisconsin Sleep
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Cohort Study, the results of the study revealed that mean blood pressure were higher
among patients with sleep apnea (AHI ≥ 5) versus patients without sleep apnea (131/80
±.7/1.1 mmHg versus 122/75 ±.9/1.2 mmHg, p < 0.05; Hla et al., 2008). The
investigators determined the odds ratio of OSA to hypertension after adjusting for
confounders such as blood pressure status at baseline, obesity, neck, waist circumference,
age, sex, weekly alcohol, and cigarette use (Hla et al., 2008, p. 795). The investigators
also found a significantly higher proportion of patients with sleep apnea, or a history of
snoring that experienced higher variability in blood pressure compared to control subjects
(p < 0.05; Hla et al., 2008, p. 795). Sleep apnea patients also showed higher odds ratio of
hypertension in a dose response fashion (Hla et al., 2008, p. 795). Grote et al., (1999)
also, cross sectionally analyzed the relationship between OSA and hypertension among
1087 males and 103 females aged 25 to 85 years old in a sleep study clinic. The study
analysis revealed that as adjusted by age, BMI, tobacco, alcohol, and cholesterol, an AHI
value of ≥40 versus AHI value of ≤ 5 was an independent predictor of systemic
hypertension [ORs 4.1] (95% CIs, 2.7-6.5; Grote et al., 1999, p. 1875). The largest cross
sectional study to provide the evidence to support OSA-hypertension relationship came
from the Sleep Heart Health Study (Nieto et al., 2000). 6132 patients, aged 40 years or
older were recruited to participate in a cross-sectional study conducted between the
period of November 1995 to January 1998 (Nieto et al., 2000, p. 1829). The main
parameters were AHI index, arousal index, percentage of sleep below 90% oxygen
saturation, and history of snoring (Nieto et al., 2000, p. 1829). The study results
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determined that the prevalence of hypertension were higher among 6132 subjects
exposed to AHI and other sleep parameters (Nieto et al., 2000, p. 1820). Despite the
possibility that the results could be influenced by body mass index; the study showed that
odds ratio for hypertension were highest among patients with AHI ≥ 30 compared to AHI
≤ 1.5 (1.37, versus [1.03-1.83], 95% CIs, p = 0.005; Nieto et al., 2000, p. 1831). The
OSA and hypertension association was seen regardless of sex, age, ethnic groups, and
weight (Nieto et al., 2000, p. 1832). Moreover, Hass et al., (2005) in a cross sectional
study of OSA patients obtained from the Sleep Heart Cohort Study showed that when
patients’ ages were stratified by 40-59 years old, to ≥ 60 years old, the association
between OSA and hypertension were more pronounced among younger patients
compared to patients ≥ 60 years old, (AHI was significantly associated with higher odds
ratio of hypertension , (AHI =15 to 29.9, ORs 2.38 [95% CIs, 1.30 - 4.38]; AHI = 30,
ORs 2.24 [95% CIs 1.10 - 4.54]; Haas et al., 2005).
Of particular importance is the first longitudinal studies conducted by Peppard et
al., (2000) which analyzed the relationship between OSA and hypertension. The
Wisconsin Sleep Cohort Study (2000) looked at subgroup of state employees from four
Wisconsin state agencies that had overnight sleep studies at four year intervals (Peppard
et al., 2000, p. 1378). After adjusting for systemic hypertension, BMI, neck
circumference, waist, and hip perimeter, age, gender, tobacco, and alcohol status, the
odds ratio for the presence of hypertension was 1.42 (95% CIs, 1.13-1.78; Peppard, et al.,
2000, p. 1378). Patients had an AHI index of 0.1 – 4.9 events per hour [95% CIs, 1.29-

41
3.17] at baseline as compared to none, AHI index of 5.0-14.9 events per hour, and 2.89
with AHI ≥ 15, (95% CIs, 1.46-5.64; Peppard et al., 2000, p. 1378). In another
longitudinal analysis of the relationship between OSA and hypertension, the first
National Health and Nutrition Examination Survey (n = 4810) measured patients aged 32
-59 years old using Cox proportional hazards models (Gangwisch, 2006). Patients were
followed-up between 1982 and 1992 to determine the incidence of hypertension (defined
by physician diagnosis, hospital record, or cause of death over 8-10 year follow-up)
among healthy sleep deprived subjects. The results of the study revealed that among
patients who had sleep durations of ≤ 5 hours/night were highly associated with increased
risk of hypertension (HRs, 2.10; 95% CIs, 1.58-2.79; Gangwisch et al., 2006, p. 833).
There were also a number of open label studies conducted to determine the effect
of treatment with CPAP on blood pressure levels of patients with OSA (Cantolla et al.,
2009). Since 2009, there were already 28 of these open label studies. The majority of
these open label studies on the effect of CPAP on blood pressure among patients with
OSA with or without hypertension syndrome showed that patients who were treated with
CPAP therapy had significantly reduced blood pressure (p = 0.05; Akashiba et al., 1999;
Borgel et al., 2004; Doherty et al., 2005; Heitmann et al., 2004; Hla et al., 2002; Huang &
Chen, 1996; Martinez-Garcia et al., 2007; Robinson et al., 2008; Tun et al., 2003; Wilcox
et al., 1993 ). There were also a number of cross-over and parallel group studies that had
looked at the relationship between OSA and hypertension. One of these cross-over,
parallel group studies shown that the effect of CPAP on blood pressure among patients
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with OSA similarly showed dropping of systolic blood pressure of 2.00 (-5,07-9.07), and
diastolic blood pressure of 2.00 (-2.38-6.38) among patients treated with 29 weeks of
CPAP (Barbe et al., 2004).
The overall results of these studies strongly suggested that dose response
association between OSA and hypertension were independent of confounding factors.
The sample sizes of the majority of studies were performed in large enough sample sizes
to obtain statistical significance. The majority of the studies however were performed
among white Caucasian men. So the lack of knowledge of associations, much less the
causality between OSA and hypertension among women, men and specific races are
enormous. Additionally, obesity is typically related with the association between OSA
and hypertension among White populations (Wolk et al., 2003). The interaction between
obesity and OSA stemmed from involvement of similar multiple pathophysiological
mechanisms and consequences (Davy et al., 2004). However, obesity is not a common
problem among Asians (Ip et al., 2001). The lack of knowledge of the association
between OSA and hypertension among Asians and the effects of other risk factors
presents additional research opportunity
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Table 2
Summary of Epidemiological Studies Evaluating Patients With OSA and Hypertension
Authors/
Year of
Publication/
Publication

Population

Design

Subject
(n) age

Age

Sleep
evaluation

Grote
et., al/1999/
Journal of
Hypertension

Sleep
study
patients

Crosssectional

6120
men and
women

60

Polysomno
graphy

Grote
et., al/2000/
Archives of
Internal
Medicine

Household
of two
counties of
southern
Pennsylva
nia
(Dauphin
and
Lebanon)

Crosssectional

4364
men and
12,219
women

20100

Polysomnogra
phy

Results
hyperten
sion
(BP>140/
90
mmHg)
or
hypertensi
on (BP>
160/100
mmHg)
Respira
tory
disturbanc
e index
higher
among
patients
with BP
160/95
mmHg,
un
controlled
hyper
tension
increased
significan
tly as
SRBD
activity
increased
(X2, p <
0.05)

Parameters

Preva
lence of
moderate
to severe
sleep
disor
dered
breathing
men -59.3
(44.4,

Age, BMI,
sex,
menopause
status, use
of HRT,
alcohol
use, and
smoking

Age, body
mass
index,
alcohol,
smoking,
and
daytime
blood
gases

44
73.1),
women 51 (27.1,
74.6).
Odds
ratio
moderate
to severe
6.85
(2.0226.36).
Mild 2.29
(1.433.61)
Nieto
et.,al/2000
/Journal of
American
Medical
Association

Population
based
cohort
studies

Crosssectional

11,053
men and
women

>40

Polysomno
graphy

Odds
ratio1.25
(1.081.44) for
AHI (1.54.9),1.57
(1.351.81) AHI
(514.9),1.73
(1.432.10) AHI
(1529.9),2.27
(1.762.92) AHI
>30

Age,
ethnicity
(No
Asians),
smoking,
alcohol
use, body
weight,
BMI, neck
circumfere
nce, waist
to hip ratio

Bixler
et.,al /2000/
Archives of
Internal
Medicine

Household
of two
counties of
southern
Pennsylva
nia
(Dauphin
and
Lebanon)

Crosssectional

4364
men and
12,219
women

20100

Polysomno
graphy

Preva
lence of
moderate
to severe
sleep
disor
dered
breathing
men -59.3
(44.4,
73.1).Wo
men – 51
(27.1,74.6
). Odds
ratio
moderate
to severe
6.85

Age, BMI,
sex,
menopause
status, use
of HRT,
alcohol
use, and
smoking

45
(2.0226.36)
Mild 2.29
(1.433.61)
Peppard, et.,
al/2000/New
England
Journal of
Medicine

State
employees

Longitud
inal

1189
men and
women

>40

Polysomno
graphy

Odds
ratio 1.66
(1.352.03) AHI
0.14.9,2.74
(1.82-4.12
) AHI
5.014.9,4.54
(2.468.36) AHI
>15

Age, sex,
BMI

Lavie,
et., al/2000/
BMJ

Patients
from sleep
laboratory

Crosssectional

2677

2085

Polysomno
graphy

Multiple
regression
analysis
ß (95%
CI) AHI
>1,0.10
(0.070.13) p =
0.0001

Age, sex,
BMI, neck
circumfere
nce, waist
to hip
ratio,
smoking,
hyperten
sive

Hass,
et., al/2005/
Circulation

Sleep
Heart
Study
participant
s

Crosssectional

6120

4060

Polysomno
graphy

Odds
ratio 1.41
(0.98–
2.03) AHI
1.5-4.9
1.49
(1.02–
2.17) AHI
5.0-14.9
1.66
(1.03–
2.67) AHI
15-29.9
1.09
(0.58–
2.06) AHI
>30

Age (No
Asians)
,race,
gender,
BMI,
smoking
history,
waist to
hip ratio

Hla, et., al/
2008/Sleep

State
employees
(Wiscon

Crosssectional

147
men and
women

3060

Polysomno
graphy

Odds
ratio 2.0
(1.2-3.2)

Age, sex,
BMI,
waist, hip

46
sin)

moderate
vs. none
2.9 (1.55.6)
severe to
none

girth,
health, BP,
smoking,
and
alcohol

Risk Factors Associated with OSA and Hypertension:
Review of Current Literature
Age
Age is an important risk factor in the development of both OSA and hypertension.
Age related changes in arterial structure and function lead to decreased distensability of
the large vessels (Franklin et al., 1997). The enlargement of the vessels contributes to
increase pulse wave activity, increase myocardial demand, and late systolic blood
pressure augmentation (Franklin et al., 1997, p. 308). The Nurses’ Health Study I, a large
cohort of 83,882 non- hypertensive women aged 27 to 44 years, determined that older
age, aside from other four risk factors (e.g., BMI, physical activity, frequency of aspirin
use, and alcohol consumption) increased the incident hypertension (Forman et al., 2009).
Participants aged 50 and younger had the lowest risk for all the five factors associated
with hypertension, while women aged 61 and older had a hazard ratio of 0.62 (95% CIs,
0-.51-0.75; Forman et al., 2009, p. 401). Cordero et al., (2011) in a multicenter, crosssectional and observatory registry of 10,743 patients with hypertension from cardiology
and primary care clinics showed that 55.4% of patients had controlled blood pressure and
slighter higher mean age of 66 years old. The STRONG Heart Study (2006) a
longitudinal study of 4549 American Indian showed that hypertension incidence was
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>38% (p= 0.051) higher among >65 years of age compared to patients aged 45-54 years
of age (Wang et al., 2006).
Large epidemiological studies have been conducted exclusively to look at the
effects of controlling hypertension on the aging population. One of these studies, Systolic
Hypertension in the Elderly (SHEP) study screened 447,921 and enrolled 2,365 subjects
assigned to active treatment (chlorthalidone 12.5 or 25 mg/day, and as needed, addition
of atenolol 25 or 50 mg/day or reserpine, 0.05 or 0.10 mg/day), and 2, 371 to placebo,
(SHEP Cooperative Research Group, 1991). The average blood pressure 170 mmHg/77
mmHg, with participants mean age of 72 years. The main outcome measures were
nonfatal and fatal (total) stroke, while the secondary measures included cardiovascular
and coronary morbidity and mortality, all-cause mortality, and quality of life measures.
The results of the study showed that after an average follow-up of 4.5, the average blood
pressure among the placebo group was 155 mmHg/72 mmHg, while the average blood
pressure for the treated group was 143 mmHg/68 mmHg, (SHEP Cooperative Research
Group, p. 3244, 1991). The 5-year incidence of total stroke was 5.2 per 100 participants
for active treatment and 8.2 per 100 for placebo. Additionally, the relative risk by
proportional hazards regression analysis was 0.64 (p = .0003) for the secondary end point
of clinical nonfatal myocardial infarction plus coronary death, while the relative risk was
0.73 for major cardiovascular events (relative risk, 0.68) and the relative risk was 0.87 for
death from all causes.
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Bixler et al., (1998) and other several studies have shown that OSA prevalence
increases with age. The study also showed that among men, OSA based on AHI ≥ 10
events/h was 3.2%, 11.3%, and 18.1% among 20- to 44-year, 45- to 64-year, and 61- to
100-year age groups, respectively (Bixler et al., 1998, p. 2289).
With advancing aging, pathologically it affects hypertension by contributing to
increase in large arterial stiffness (Benetos et al., 2002). While, symptomatically in a
majority of men and women aged 45 and older, manifestations of sleep related difficulties
are highly common (Bixler et al., 2001).
Indeed it has been shown in several researches that age increased the prevalence
of OSA associated to hypertension; however, whether it increases the risk of prevalence
of OSA association to hypertension among middle aged Asians is uncertain.
Craniofacial features
Craniofacial features play a significant effect on the occurrence of OSA among
Asians (Aihara et al., 2012). Davidson et al., (2005) postulated that evolutionary changes
in the upper respiratory tract inclined men to OSA. The study revealed that among 133
male with OSA who underwent unattended multi-channel home sleep studies had
positive correlation between AHI, klinorchy, laryngeal descent, and craniobase
angulation (Davidson et al., 2005, p. 497). Numerous studies involving the use of
various measures including radiography, computerized tomography, and magnetic
resonance imaging showed that craniofacial abnormalities associated with OSA include
retrognathia, tonsillar hypertrophy, enlarged tongue or soft palate, inferiorly positioned
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hyoid bone, maxillary and mandibular retro position, and decreased posterior airway
space can narrow upper airway dimensions (Cistulli et al., 1996). Aihara et al., (2012) in
a cross sectional study of 134 Japanese male patients revealed from multiple regression
analysis that age, BMI, position of hyoid bone, and proximal airway resistance were
significantly related to AHI (p < 0.05). Chang et al., (2008) in a cross-sectional study of
84 males and 15 female Chinese patients from sleep centers in Taipei Veterans General
Hospital from July 2002 to June 2006 craniofacial measurements of gnathion-gonion,
anterior superior hyoid mandibular plane, posterior nasal spine to the velum tip, and
widest point of the soft palate were positively correlated to AHI.
Regardless of the absence of craniofacial abnormalities, slight difference in the
maxillary or mandibular size can be a risk factor to the development of OSA (Punjabi et
al., 2008). A qualitative and meta-analysis of the literature explained that mandibular
body length best predicted the increased risk of OSA (Miles et al., 1996).
However, differences in craniofacial morphology can explain the variability of
risk among certain ethnic groups (Punjabi et al., 2008, p. 139). A study conducted among
Chinese patients revealed that the crowded upper airway and relative retrognathia
compared to Whites contributed to OSA risk (Lam et al., 2005). The craniofacial
features, like shorter cranial base and acute cranial base flexure affected the incidence of
OSA of other Asians (Li et al., 2000). Based from these evidences, clearly it showed that
given the differences among Asians groups, studying the effects of these craniofacial
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differences in the risk of OSA and its relationship to hypertension is of paramount
importance.
Obesity
The Wisconsin Sleep Study, the Sleep Heart Study, Cleveland Family Study and
others have shown that obesity is not only a significant risk factor for OSA but for
hypertension as well (Punjabi, 2008). Moreover, the Wisconsin Sleep Study described a
one standard deviation in BMI was associated with four-fold intensification OSA
prevalence (Young et al., 1993). Epidemiological evidence among various White,
Korean, and Chinese populations had also described excess body weight as highly
correlated with increased in OSA prevalence (Duran et al., 2001; Ip et al., 2001; Ip et al.,
2004; Kim et al., 2004; Peppard et al., 2000; Young et al., 1993). Epidemiological
evidence among hypertension studies had also shown that obesity was also associated
with inducing and accelerating renal complications in essential hypertension (Narkiewicz,
2006). However, an interesting observation made by studies conducted abroad showed
that while Asians were less obese than Whites, the disease prevalence for a given sex,
age, and BMI was higher compared to Whites (Li, et al., 2000; Ong & Clerk, 1998).
Despite the vast amount of evidence to support increased prevalence of obesity to
OSA and hypertension, controversy still remains as to whether this risk factor reflect an
increase risk of OSA and hypertension among middle-aged Asians in the United States.
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Summary
Both OSA and hypertension are pervasive disorders that affect significant
proportion of the United States population. The sufficient component cause theory
supports the ideology of multifactorial etiology in the association between OSA and
hypertension. Asians are underrepresented in OSA and hypertension studies, even as
their great number in the US population is steadily increasing. There have been
significant amount of studies that had shown the association between OSA and
hypertension. Again these studies do not significantly represent Asians, thus these
observed OSA and hypertension relationships have not been fully recognized. A better
understanding of the factors contributing to the observed OSA and hypertension
association among Asians is warranted. Knowledge of other mitigating risk factors like
craniofacial features might inform the development of specific management, treatment
and prevention strategies that can confer optimization of treatment of these diseases.
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Chapter 3: Research Method
Introduction
OSA-hypertension epidemiology has been well researched among predominantly
White populations; whereas data for middle-aged Asians are limited. The compelling
evidence of the association of OSA and hypertension has mostly been based on White
populations specifically those residing in North America, Europe, and Australia and may
not be applicable to Asians (Villanueva et al., 2005). Studies done in Asia indicate that
the prevalence rate of OSA among Asians is probably comparable to or even higher than
the rate among U.S and European Whites (Ip et al., 2001; Kim, et al., 2004). However,
these rates could be different from the actual rates among Asians living in the United
States. The difference in rates seen in various studies can be attributed to a number of
factors that may confound the results, including differences in sleep study techniques,
clinical outcomes, genetic factors, and diet and lifestyle (Villanueva et al., 2005, p. 419).
The difference in rates can also be attributed to differences in fundamental characteristics
such as age, sex, person, place, time, and race (Labarthe, 2011). Although a number of
epidemiological studies linking OSA with increased risk of hypertension have been
performed, few studies using similar methods have observed these relationships among
middle-aged Asians in the United States. It is also uncertain whether in the United States
OSA is common among Asians and if OSA is also associated with hypertension.
This section of the study addresses the research design and rationale,
methodology, and threats to validity.
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Research Design and Rationale
A cross-sectional study design was used to determine (a) the prevalence rate of
OSA among middle-aged Asian patients (Chinese, Filipino, Vietnamese, Asian Indian,
Korean, Taiwanese, Japanese, and Singaporean) in San Jose, CA; (b) the association
between OSA and hypertension, and (c) the association of other risk factors--body mass
index (BMI); Mallampati score (MS); the Epworth Sleepiness Scale (ESS), and ApneaHypopnea Index (AHI) with hypertension as the outcome. The cross-sectional design of
this study was the suitable study design to describe the burden and distribution of OSA in
association with hypertension among this population of interest (Babbie, 2010). This
study design also allowed me to make observations about the prevalence and
characteristics of this disease in a distinct population during a certain period of time
(Gordis, 2004, p. 195). The general design of a cross-sectional study consist of looking
at a slice of the population to examine characteristics associated with a disease by
comparing cases to noncases and performing predefined measurements or ascertainments
(Gordis, 2004, p.196). This can be accomplished by examining a population of n persons
for the study, then identifying the presence or absence of the disease for each subject
(Gordis, 2004, p. 197). This study design allows the determination of prevalent cases at a
fixed point in time. One constraint of this study design is that although association may
be obtained for the possible risk factor(s), temporal association cannot be highly
determined (Gordis, 2004, p. 198). This type of study design is appropriate for
determining the prevalence of OSA with hypertension (Gordis, 2004, p. 195). The other
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limitation of a using cross-sectional study design is that the confounding factors may not
be equally distributed between groups (Babbie, 2010, p. 106). This unequal distribution
of confounding factors can lead to bias and misinterpretation (Babbie, 2010, p, 106).
Biases include selection, recall, length, and biased sampling. Selection bias can be
addressed by ensuring that the study is powered enough to represent the target
population. Recall bias can be addressed by clearly describing the problem and gaining a
thorough understanding of the available evidence before data collection (Varkevisser et
al., 2003). A clearly defined problem can enable the investigator to formulate specific
objective(s) and sample the right population of interest (Varkevisser et al., 2003, p.195).
Length biased sampling can be eliminated by knowing the duration of the disease of
interest to avoid overrepresentation or underrepresentation of the said disease
(Varkevisser et al., 2003, p. 195). The other variables of interest were age, gender,
smoking consumption, body mass index (BMI), Epworth Sleepiness Scale (ESS),
Mallampati score (MSS), and Apnea and Hypopnea (AHI).
Methodology
Population
The data that were generated for this study originated from patients living in San
Jose, CA. The target populations for this study were Asians (Chinese, Filipino,
Vietnamese, Asian Indian, Korean, Taiwanese, Japanese, and Singaporean) residing on
southern side of San Jose, CA who had visited the sleep clinics between January 1, 2008
to December 31, 2011. A total of 462 middle-aged Asian patients were needed to
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perform this study and were randomly selected from three major sleep study clinics in
San Jose, CA. The recruitment and selection of the eligible patients were accomplished
by random sampling. The inclusion criteria for these patients were the following: (a)
men and women between 35 and 60+ years of age who had observed apneas, daytime
fatigue, daytime sleepiness, or snoring who were referred to sleep study clinics; (b)
diagnosis of OSA verified by overnight polysomnograms, and (c) a systolic blood
pressure [SBP] level of 140mmHg, and a diastolic blood pressure [DBP] level of 90 mm
Hg). Eligible patients needed to have a completed physical examination. The exclusion
criteria for the study included patients with physical or psychological incapacity, no selfreported history of hypertension, no current or self-reported treatment for OSA, no
previous treatment for snoring or any previous CV event (myocardial infraction, unstable
angina, transient ischemic stroke, or attack, myocardial revascularization), chronic
disease, and drug or alcohol addiction. Patients were also excluded if they had severe
congestive heart failure (NYHA class IIIb or IV), known cardiomyopathy, valvular
disease, coronary artery disease, diabetes mellitus, current active liver disease,
unexplained elevated serum creatine kinase (CK > 3XULN), cancer, uncontrolled
hyperthyroidism, or other important comorbidities.
Sampling and sampling procedures
The sample population for the study was independently and randomly selected
from three sleep study clinics in San Jose, CA. The sample size needed was calculated
and a third of the sample was collected from each clinic.
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A simple random sampling procedure was used to select the study participants.
The research study of interest involved widely dispersed large populations of patients.
The use of simple random sampling allowed equal opportunity for all sets within the
population to be sampled (Anderson & Finn, 1997). In cross-sectional studies, the power
is estimated by factoring in the sample size among the exposed and nonexposed with the
desired confidence interval (Portney & Watkins, 1993, p. 236). In order to determine a
sample size that would be sufficient to power the study, the following considerations
were used: margin of error -- 5%; confidence level --95%; estimated prevalence of OSA
based on limited studies among Asians outside of the United States -- 4%, (Cantolla, et
al., 2009; Kamil, et al., 2007; Kim, et al., 2004; Punjabi, 2008; Vozoris, 2012). The
sample calculation based on the following equation:

N=

t² x p(1-p)
m²

Where n is the sample size, t is confidence level at 95% (standard value of 1.96),
p is the estimated prevalence, and m is the margin of error at 5% (standard value of 0.05)
Kadam & Bhalerao, 2012).
n = 1.962 x .4 (1- .4)
0.052
n = 3.8416 x .4 (.6)
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0.0025
n = .9219
0.0025
n = 460
460 divided by three clinics is 153.333. The number of subgroups in each of the
three clinics to be sampled is an important consideration in the study. Because an equal
number of male and females subjects in each of the three clinics was considered,
n=153.33 will be rounded to whole persons to154.
Based from this calculation, the number of subjects needed for the analysis is 462
(Kadam & Bhalerao, 2010). The total patients (n) equals’ 462 subjects will be divided
among the three sleep clinics. The total patient (n) for each sleep clinics is 154. A
schematic representation of the sampling strategy is presented in the figure below.
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Figure 2. Sampling design
Procedures for Recruitment, Participation, and Data Collection
All the study subjects who were recruited were approved by the Human and
Research Committee of Walden University (Institutional Review Board approval 03-2514-0153639). The study was also conducted in accordance to the principles of human
research protections as specified by the Declaration of Helsinki. All study subjects who
qualified for the study had to meet the study inclusion, and exclusion criteria. The data
that were collected for the study were obtained with the use of paper and electronic
medical records (EHR). Since, this study only used secondary data; all data collected
were subjected to confidentiality. The data regarding patient demographics, patient’s
history, anthropometric measurements, physician diagnoses, and laboratory results were
extracted from paper and electronic health records. In order to ensure data
confidentiality, I obtained sample confidentiality agreement from each of the sleep study
clinics. The data collected were extracted from patient records that were identified by the
medical staff as Chinese, Filipino, Vietnamese, Asian Indian, Korean, Taiwanese,
Japanese, and Singaporean. The cross-sectional nature of the study, as well as the use of
paper and electronic health records does not require debriefing patients, or any need for
follow-ups. The physician in charge in each of the three sleep study centers in San Jose,
CA provided permission to use data obtained from the paper and electronic health record.
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Sample data use agreements were obtained to ensure that data obtained were limited to
the prevalence rate of OSA in association with hypertension among Asian Americans in
San Jose, CA.
Clinical Definition of OSA
The clinical definition of OSA was in accordance with the Adult OSA Task Force
of the American Academy of Sleep Medicine (2009) as “occurrence of daytime
sleepiness, loud snoring, witnessed breathing interruptions or awakenings due to gasping
or choking in the presence of at least five obstructive respiratory events (apneas,
hypopneas or respiratory effort related arousals) per hour of sleep”. OSA was also
clinically defined by the presence of 15 or more of observed respiratory events per hour
of sleep in the absence of sleep related symptoms (AASM, 2009, p. 263). The categories
of OSA were defined according to the AHI groups, as follows; group 1 (AHI < 5); group
2 (5 ≤ AHI < 15); group 3 (15 ≤ AHI < 30); and group 4 (AHI ≥ 30; AASM, 2009, p,
263-264).
Clinical Definition of Hypertension
Hypertension was defined as high blood pressure, in which the arteries have
persistent high arterial pressure. Based from the Seventh Report of the Joint National
Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
(JNC 7), the categories of hypertension will be; group 1 (pre-hypertension, SBP, 120139 mmHg, DSP, 80-89 mmHg); group 2 ( stage 1 hypertension, SBP, 140-159 mmHg,
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DSP, 90-99 mmHg), and group 3 ( stage 2 hypertension, SBP ≥ 160 mmHg, DSP, ≥ 100
mmHg).
Polysomnography
All patients were qualified if they did at least one overnight polysomnographic
study at a sleep center in San Jose, CA. The polysomnographic study will include the
following measurements: electroencephalogram (EEG, C3 and C4), electro-oculogram
(EOG), chin, and leg electromyogram (EMG), and electrocardiography, (ECG, modified
V2 lead). Oronasal flow, thoracic, and abdominal measurements by inductive
plethysmography and oxygen saturation will be used to measure respiration. Sleep
disruption and EEG arousals will be detected by PSG recordings from skin surface
electrodes per current AASM criteria for sleep/wake and cortical arousal determination,
(Chang, et al., 2008). All the records were scored according to scoring criteria
established by Rechtschaffen and Kales (1968), the American Sleep Disorders
Association (Thornton et al., 2012). This scoring criterion, used in various populations,
including Asians based from studies conducted outside the U.S, was validated to be fairly
accurate in the diagnosis of OSA (Thornton et al., 2012, p. 425). This scoring criterion
has been the standard scoring system used by physicians to diagnose OSA.
Sleepiness
The study used the definition of sleepiness using the Epworth Sleepiness Scale
(ESS). This is an eight item questionnaire, with scores ranging from 0 (the least sleepy)
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to 24 (the most sleepy) Chung et al., 2000). The ESS total score is the sum of the eight
scores with points ranging from 0 to 24 (Gonzales et al., 2011).
BP Measurements
A non-invasive blood pressure measurement in office for at least two
measurements was used to determine diagnosis of hypertension.
Neck Circumference
The study used neck circumference measurement as placing the tape at the level
of the cricothyroid membrane the night before the polysomnography.
Body Mass Index (BMI)
The subjects BMI were calculated by dividing a person’s weight in kilograms (kg)
by the person’s height in meters squared. BMI measurement was also be calculated by
multiplying weight in pounds (lbs.) by 705 and then dividing by height in inches (in.)
twice. A healthy BMI is in the range of 18.5 to 24.9, while BMI over 30 is considered
obese.
Mallampati Score
The Mallampati Scoring System (MSS) was used to assess the patients’
oropharyngeal region. The healthcare professional needed to identify the four anatomical
landmarks in the oropharyngeal region. MSS was classified according to four groups:
group 1, Class I (all anatomical structures can be visualized); group 2, Class II (soft
palate, hard palate and upper portions of the uvula and tonsils can be visualized); group 3,
Class III (only soft, hard palate and base of the uvula can be visualized); and group 4,
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Class IV (only the hard palate can be visualized), (Gonzales, et al., 2011, p. 3).
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Table 3
Summary of Variables
Type of variable
Categorical
a. Nominal

Numeric
a. Discrete

b.

Description of variable

SPSS Variable Name

Identification number

ID

Sex

Sex

Race

Race

Smoking status

Smoking status

Hypertension

Hypertension status

Mallampati score

MS score

OSA status

OSA status

Snoring

Snoring

ESS score

ESS score

AHI score

AHI score

Age
BMI
Neck circumference

Age (years)
BMI
Neck circumference
(inches)
BP measurements
(systolic/diastolic
pressure)

Continuous

BP measurements

Coding instructions

0-Female
1-Male
1-Chinese
2-Filipino
3-Vietnamese
4-Asian Indian
5-Korean
6-Taiwanese
7-Japanese
8-Singaporean
0-No
1-Yes
0-No
1-Yes
1-Class1
2-Class II
3-Class III
4-Class IV
0-No
1-Yes
0-No
1-Yes
Total ESS score
(range from 0=low to
24=high daytime
sleepiness)
AHI score
(range from 5 and above)
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Procedures for Archival Data
In order to address data integrity, the data was accessed only by qualified users,
audit trails on all changes will be logged and specific controls over identification codes
and passwords will be instituted. Only data pertinent to the study protocol was collected
and no extra data was collected. If it is appropriate, cross checks were imposed to ensure
inclusion/exclusion criteria and procedures are appropriately collected. Examples of
cross-checks are age, blood pressure ranges, AHI, etc. Cross checks of procedure
sequence were also followed. For example, the study required that polysomnography
should be done before the determination of OSA; MSS scores were done prior to
determination of MSS scores, etc. The study ensured that specific designs for collecting
analyzable data were followed. For example, numeric analysis required numeric data,
and categorical analysis required categorical data. Standard units for each of the
measureable data were followed to ensure data collected were reliable and valid.
Laboratory data collected were reconciled, which mean that each subject have matching
information, laboratory values were consistent and laboratory ranges were not different.
The data should also be cleaned. I avoided duplication errors, eliminated ambiguous
responses from subjects, and checked missing responses (Prokscha, 2012). I also
obtained permission to collect and use data by ensuring that proper forms and
requirements as per Walden University’s Office of Research Ethics and Compliance
(IRB) were duly met and submitted prior to data collection.
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Data Analysis Plan
The latest version of SPSS, version 21 was used for data analysis. The analysis of
patients included in the study was obtained from paper and electronic medical records
(EMR). EMRs are paperless or digital versions of patients’ charts. The cleaning and
screening in patients for data analysis only involved analyzing patient demographics.
The patient demographics in paper and EHR included gender, age, race, smoking status,
hypertension status, systolic diastolic blood pressure readings, neck circumference, body
mass index (BMI), snoring status, Epworth Sleepiness Scale (ESS), Mallampati score
(MS), Apnea, and Hypopnea Index (AHI). The other items that were included in the
paper and EHR database for analysis included medical history, family history, diagnosis
codes, laboratory data, and prescription data.
The analysis determined the estimated unadjusted age, BMI, smoking, alcohol
status, and neck circumference effect on OSA, and its association with hypertension.
Mean and frequency of distribution were calculated for gender, age, ethnicity, smoking
status, hypertension status, snoring and OSA status. Mean, mean standard deviation,
standard deviation, and variance were also calculated for gender, age, ethnicity, smoking
status, systolic, diastolic, neck circumference, BMI, snoring, Epworth Sleepiness Scale,
Mallampati score, Apnea Hypopnea Index, OSA status and AHI groups. The continuous
variables were expressed as means ± standard deviation (SD). The subjects’ age, BMI
and Mallampati scores were considered independent confounding variables. The
variables of interest (BMI, MSS, ESS and AHI) were not adjusted by age. These
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variables were analyzed in the study because other epidemiologic evidence conducted
among predominantly White populations showed that these factors affected the
prevalence of OSA among Caucasians. The associations of different variables to
hypertension were analyzed by logistic regression analysis. The odds ratios (ORs) of
OSA association with hypertension were calculated for ethnicity, age, gender, smoking,
BMI, MSS, ESS, and AHI.
Descriptive statistics were performed in the defined categorical variables in the
study. Frequencies tabulations were utilized for gender, sex, race, smoking, and alcohol
history, elevated blood pressure, and history of hypertension. Descriptive statistics for
continuous variables (e.g., age) which enlisted the summary statistics included n, mean,
mean standard deviation, standard deviation, and variance. The study also included the
use of tables to describe and explore the data.
The specific hypotheses of the study expressed in the null form were statistical
analyzed by the following
Null Hypothesis1. There was no association between OSA and hypertension
among a sample of middle-aged Asians living in San Jose, CA.
In order to determine the association between OSA and hypertension, the study
conducted logistic regression analysis. OSA and hypertension were evaluated first as a
binary response, denoted as either yes or no. SPSS coding was denoted as 0- No and 1Yes. Binary response variables described the proportion of the population specified in the
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analysis (Grobee & Hoes, 2009). The binary response variable was calculated using the
following formulary:
ln

Y / (1-Y)

= b0 + b1X1 which calculated the odds. Where Y is

representative of the proportion of the subjects with the outcome, the probability of the
disease is represented by (1-Y), and the probability of the study subjects who do not have
the disease is represented by ln [Y/ (1-Y)] is the odds of the disease. Additionally, b0 is
the intercept for the odds of the disease and X1 is the intercept for the independent
variable (Grobbee & Hoes, 2009, p. 345).
The measure of association between the outcome of interest and predictor variable
was measured using odds ratio. The level of significance was evaluated at 0.05.
Null hypothesis 2. There was no association between age and hypertension
among a sample of middle-aged Asians living in San Jose, CA.
In order to determine the association between age (continuous variable), and
hypertension (categorical variable) among a sample of middle aged Asians living in San
Jose, CA, the study conducted logistic regression analysis. This type of analysis can
better explain the functional relationship of OSA and other variables (WassertheilSmoller, 1990).
The absolute probability or the risk of the outcome for each of the subjects was
also be calculate using logistic regression by substituting the coefficients for each
determinants with the use of the formula:
P = 1/ 1+ e – (ß0+ß1x1+ß2x2+…..)
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The measure of association between the outcome of interest and predictor variable
was measured using odds ratio. The level of significance was evaluated at 0.05.
Null hypothesis 3. There was no association between gender and hypertension
among a sample of middle-aged Asians living in San Jose, CA.
In order to determine the association between gender and hypertension
(categorical variables) among a sample of middle-aged Asians living in San Jose, CA, the
study conducted logistic regression analysis. This type of analysis can better explain the
functional relationship of OSA and other variables (Wassertheil-Smoller, 1990). The
absolute probability or the odds of the outcome for each of the subjects was also
calculated using logistic regression by substituting the coefficients for each determinant
with the use of the formula:
P = 1/ 1+ e – (ß0+ß1x1+ß2x2+…..)
The measure of association between the outcome of interest and predictor variable
was measured using odds ratio. The level of significance will be evaluated at 0.05.
Null hypothesis 4. There was no association between smoking consumption and
hypertension among a sample of middle-aged Asians living in San Jose, CA.
In order to determine the association between smoking and hypertension
(categorical variables) among a sample of middle-aged Asians living in San Jose, CA. the
study conducted logistic regression analysis. This type of analysis can better explain the
functional relationship of OSA and other variables (Wassertheil-Smoller, 1990). The
absolute probability or the odds of the outcome for each of the subjects was also be
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calculated using logistic regression by substituting the coefficients for each determinant
with the use of the formula:
P = 1/ 1+ e – (ß0+ß1x1+ß2x2+…..)
The measure of association between the outcome of interest and predictor variable
was measured by using odds ratio. The level of significance was evaluated at 0.05 level
of significance.
Null hypothesis 5. There was no association between body mass index (BMI) and
hypertension among a sample of middle-aged Asians living in San Jose, CA.
In order to determine the association between body mass index (BMI) (continuous
variable) and hypertension (categorical variables) as the outcome among a sample of
middle aged Asians living in San Jose, CA, the study conducted logistic regression
analysis. The binary response variable was calculated using the following formulary:
lnY/ (1-Y)= b0 + b1X1 which will calculate the odds. Where Y is representative of
the proportion of the subjects with the outcome, the probability of the disease is
represented by (1-Y), and the probability of the study subjects who do not have the
disease is represented by ln [Y/ (1-Y)] is the odds of the disease. Additionally, b0 is the
intercept for the odds of the disease andX1 is the intercept for the independent variable,
(Grobbee & Hoes, 2009, p. 345).
Null hypothesis 6. There was no association between Mallampati Score (MS) and
hypertension among a sample of middle-aged Asians living in San Jose, CA.
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In order to determine the association between Mallampati score (MS) and
hypertension (categorical variables) among a sample of middle aged Asians living in San
Jose, CA, the study conducted logistic regression analysis. This type of analysis can
better explain the functional relationship of OSA and other variables (WassertheilSmoller, 1990). The absolute probability or the risk of the outcome for each of the
subjects was also calculated using logistic regression by substituting the coefficients for
each determinant with the use of the formula:
P = 1/ 1+ e – (ß0+ß1x1+ß2x2+…..)
The measure of association between the outcome of interest and predictor variable
was measured using odds ratio. The level of significance was evaluated at 0.05.
Null hypothesis 7. There was no association between Epworth Sleepiness Scale
(ESS) and hypertension among a sample of middle-aged Asians living in San Jose, CA.
In order to determine the association between ESS and hypertension (categorical
variables) among a sample of middle-aged Asians living in San Jose, CA, the study will
conduct logistic regression analysis. This type of analysis can better explain the
functional relationship of OSA and other variables (Wassertheil-Smoller, 1990). The
absolute probability or the odds of the outcome for each of the subjects was also
calculated using logistic regression by substituting the coefficients for each determinant
with the use of the formula:
P = 1/ 1+ e – (ß0+ß1x1+ß2x2+…..)
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The measure of association between the outcome of interest and predictor variable
was measured using odds ratio. The level of significance was evaluated at 0.05.
Null hypothesis 8. There was no association between Apnea-Hypopnea index
(AHI) and hypertension among a sample of middle-aged Asians living in San Jose, CA.
In order to determine the association between Apnea-Hypopnea Index (AHI) and
hypertension (categorical variables) among a sample of middle aged Asians living in San
Jose, CA, the study conducted logistic regression analysis. This type of analysis can
better explain the functional relationship of OSA and other variables (WassertheilSmoller, 1990). The absolute probability or the odds of the outcome for each of the
subjects was also calculated using logistic regression by substituting the coefficients for
each determinant with the use of the formula:
P = 1/ 1+ e – (ß0+ß1x1+ß2x2+…..)
The measure of association between the outcome of interest and predictor variable
was measured using odds ratio. The level of significance was evaluated at 0.05.
Each of the specified hypotheses included this table in a similar format
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Table 4
Sample table of results

SE
Step

Wald

f

Sig

Exp(B)

Lower

Presence
of HTN
Constant

Threats to Validity
Threats to validity can be external or internal (Groves et al, 2009). The external
validity addressed the question of how the results of the study could be generalized to the
population (Groves et al., 2009, p. 373). In order to address the external validity of the
study, the study strictly adhered to the study’s inclusion and exclusion criteria. The study
also clearly defined the variables; provided detailed description of the study
methodology; clearly explained the instrumentation, and measurements used in the study
and openly provided the protocol for data collection (Groves et al, 2009, p. 373). There
are various types of internal validity associated with cross-sectional studies. Construct
validity as such is one of them. Construct validity assures that possible causal
relationships exists between a variable to another. In this particular study, numerous
epidemiological studies have shown such relationships among predominantly White
populations. Thus, this study postulated that such relationship can also be seen among
Asian patients. There other internal validity issue for the study. Face validity being one
of them, was addressed by ensuring that the appropriate statistical measurement for the

95% CI
for exp
(B)
Upper
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various variables to be used was appropriate for study analysis. This was established by
consulting statistical references and literatures with similar study design, methods, and
patient population. The other internal validity issue was selection of study subjects.
Although, I did a careful analysis of the existing literature, and considered all known
variables that may affect the study results, other confounders can still influence the
results of the study. These include other existing medical conditions, and other risk
factors that may affect the disease. Selection maturation, an internal validity issue, can
occur when study subjects mature at different speeds (Asmundson et al., 2002). In cross sectional studies such as this one, although subjects maybe of the same age, other factors
may affect outcomes, and thus the study may not be able to differentiate between
maturation and cohort differences (Olsen & St. George, 2004). The study tried to address
this issue by ensuring that age is factored into the analysis.
Ethical Concerns
The study strictly adhered to the widely accepted standards for ethical,
professional and scientific conduct of the study from study design and implementation.
The study adhered to the principles as set forth by Walden University’s IRB, which
included confidentiality agreement, data use agreement, and authorization to disclose
private health information (PHI). In order to do this, the study strictly viewed all patient
data as highly confidential, and respected the study subject’s cultural and social
differences (Groves et al., 2009). The investigator also observed the highest level of
professional integrity in the conduct of all the stages of the study (Groves et al., 2009, p.
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373). The investigator also made sure that the findings was reported accurately (Groves
et al., 2009, p.375). The study also advocated following appropriate quality control
procedures (Groves et al, 2009, p. 375). All materials were documented in relation to the
ethical conduct of the study (Groves et al., 2009, p. 375). All data procured abided by the
standards set forth by Walden University’s IRB process that included: obtaining consent
forms, confidentiality agreements, letter of cooperation, data collection request, data use
agreement, and authorization to disclose PHI. If participants refuse to grant such request;
the investigator will comply, and obtain information from subjects who would consent to
the use of PHI.
Summary
In order to determine the prevalence of OSA in association with hypertension, the
study conducted a cross-sectional survey of middle-aged Asians living in San Jose, CA.
The study analyzed paper and electronic medical records of 462 patients randomly
selected at three sleep study centers in San Jose, CA. The study employed random
sampling to eliminate bias in participant selection and limited the possibility of
confounders affecting the results of the study. The study also employed frequencies
tabulations and logistic regression analysis to determine the prevalence rate of OSA in
association with hypertension together with other risk factors including age, gender,
smoking status, ESS, BMI, MSS, and AHI. All data that I collected for the study,
including the processing of data collection, management, and data analysis abided with
the rules and regulations as set forth by Walden University’s Office of Research Ethics
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and Compliance (IRB). This guaranteed that all data obtained and all outcomes presented
were all under the pretext of highest standards of integrity and ethical procedures.
The next chapter will discuss the data collection and results.
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Chapter 4: Results
Introduction
The main purpose of this quantitative cross sectional study was to determine (a)
the prevalence rate of OSA among middle-aged Asian patients (Chinese, Filipino,
Vietnamese, Asian Indian, Korean, Taiwanese, Japanese, and Singaporean) in San Jose,
CA.; (b) the association between OSA and hypertension; and (c) the association of other
risk factors --age, gender, smoking, body mass index (BMI); Mallampati score (MS), the
Epworth Sleepiness Scale (ESS) and Apnea-Hypopnea Index (AHI) --with hypertension
as the outcome.
This section addresses the results of the study.
Results
Research Questions and Hypotheses
The overarching research question involved determining the association of OSA
and other risk factors as related to hypertension among middle-aged (40-60+ years old)
Asians living in San Jose, CA. To answer the above research question, the following sub
questions were examined.
Research Question 1. What was the association between OSA and hypertension
among a sample of middle-aged-Asians living in San Jose, CA?
Null Hypothesis 1. There was no association between OSA and hypertension
among a sample of middle-aged-Asians living in San Jose, CA.
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Alternative Hypothesis 1. There was an association between OSA and
hypertension among a sample of middle-aged Asians living in San Jose, CA.
Research Question 2. What was the association between age and hypertension
among a sample of middle-aged-Asians living in San Jose, CA?
Null Hypothesis 2. There was no association between age and hypertension
among a sample of middle-aged Asians living in San Jose, CA.
Alternative Hypothesis 2. There was an association between age and hypertension
among a sample of middle-aged Asians living in San Jose, CA.
Research Question 3. What was the association between gender and hypertension
among a sample of middle-aged Asians living in San Jose, CA?
Null Hypothesis 3. There was no association between gender and hypertension
among a sample of middle-aged Asians living in San Jose, CA.
Alternative Hypothesis 3. There was an association between gender and
hypertension among a sample of middle-aged Asians living in San Jose, CA.
Research Question 4. What was the association between smoking status and
hypertension among a sample of middle-aged Asians living in San Jose, CA?
Null Hypothesis 4. There was no association between smoking status and
hypertension among a sample of middle-aged Asians living in San Jose, CA.
Alternative Hypothesis 4. There was an association between smoking status and
hypertension among a sample of middle-aged Asians living in San Jose, CA.
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Research Question 5. What was the association between body mass index (BMI)
and hypertension among a sample of middle-aged Asians living in San Jose, CA?
Null Hypothesis 5. There was no association between body mass index (BMI)
and hypertension among a sample of middle-aged Asians living in San Jose, CA.
Alternative Hypothesis 5. There was an association between body mass index
(BMI) and hypertension among a sample of middle-aged Asians living in San Jose, CA.
Research Question 6. What was the association between Mallampati score (MS)
and hypertension among a sample of middle-aged Asians living in San Jose, CA?
Null Hypothesis 6. There was no association between Mallampati score (MS) and
hypertension among a sample of middle-aged Asians living in San Jose, CA.
Alternative Hypothesis 6. There was an association between Mallampati score
(MS) and hypertension among a sample of middle-aged Asians living in San Jose, CA.
Research Question 7. What was the association between Epworth Sleepiness
Scale (ESS) and hypertension among a sample of middle-aged Asians living in San Jose,
CA?
Null Hypothesis 7. There was no association between Epworth Sleepiness Scale
(ESS) and hypertension among a sample of middle-aged Asians living in San Jose, CA.
Alternative Hypothesis 7. There was an association between Epworth Sleepiness
Scale (ESS) and hypertension among a sample of middle-aged Asians living in San Jose,
CA.
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Research Question 8. What was the association between Apnea-Hypopnea Index
(AHI) and hypertension among a sample of middle-aged Asians living in San Jose, CA?
Null Hypothesis 8. There was no association between Apnea-Hypopnea Index
(AHI) and hypertension among a sample of middle-aged Asians living in San Jose, CA.
Alternative Hypothesis 8. There was an association between Apnea-Hypopnea
Index (AHI) and hypertension among a sample of middle-aged Asians living in San Jose,
CA.
The analysis determined the association between OSA, age, gender, smoking
status, body mass index, Mallampati score, Epworth Sleepiness Scale, and apneahypopnea index to hypertension. Means, standard deviation, and frequency of
distribution were calculated for continuous independent variables such as age, gender,
ethnicity, sex, and BMI.
The purpose of this chapter is to provide the précis of the collected data, the
statistical analyses and mechanics of the analysis.
Data collection
This study used cross sectional design. After obtaining Institutional Review
Board approval (03-25-14-0153639), data were collected among Asian men and women
patients between the ages of 35 and 60+ years of age who had observed obstructive sleep
apneas living in San Jose, CA or Santa Clara County. For this study, eligible patients
were randomly selected from each of the three identified sleep study clinics located in
San Jose, CA who were seen from January 1, 2008 to December 31, 2011. Inclusion
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criteria were the following: a. men and women 35- 60+ years of age who had observed
apneas, daytime fatigue, daytime sleepiness, or snoring who were referred to sleep study
clinics; b. diagnosis of OSA verified by overnight polysomnograms; and c. a systolic
blood pressure [SBP] level of 140mmHg and a diastolic blood pressure [DBP] level of 90
mm Hg). All eligible patients completed a physical examination. Consequently,
exclusion criteria were applied to patients with physical or psychological incapacity, no
self-reported history of hypertension, no current or self-reported treatment for OSA, no
previous treatment for snoring or any previous CV event (myocardial infraction, unstable
angina, transient ischemic stroke, or attack, myocardial revascularization), chronic
disease, and drug or alcohol addiction. Patients were also excluded if they had severe
congestive heart failure (NYHA class IIIb or IV), known cardiomyopathy, valvular
disease, coronary artery disease, diabetes mellitus, current active liver disease,
unexplained elevated serum creatine kinase (CK > 3XULN), cancer, uncontrolled
hyperthyroidism, or other important comorbidities. Personnel at all three sites provided
consent by signing the data collection request form and data use agreement forms. All
sites were furnished with a copy of the approved dissertation proposal.
Data collection started in July 2014 and ended in October 2014. The
polysomnographic information of patients was obtained by randomly choosing the
appointment days that fall between January 1, 2008 and December 31, 2011. Eligible
patients were drawn from a list of patients that each physician at each site identified. The
list contained no patient names, but did contain dates. A medical assistant then retrieved
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the patient records and provided the data needed for analysis. The following data were
collected from the medical records of eligible patients: age, gender, ethnicity, smoking
status, history of hypertension, systolic blood pressure, diastolic blood pressure, neck
circumference, Body Mass Index (BMI), snoring (yes or no), Epworth scale (ESS),
Mallampati score, and Apnea Hypopnea Index (AHI). A total of 462 middle-aged Asian
patients (Chinese, Filipino, Vietnamese, Asian Indians, Korean, Taiwanese, Japanese,
and Singaporean) were randomly selected among the three sleep study clinics. From
Sites 1 and 2, data were collected on a totaled of 308 patients; however, Site 3 only had
80 eligible patient’s data. In order to meet the requirement 154 from each site, additional
data were collected from Site 1. Table 5 summarizes the demographic information of the
study sample
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Table 5
Demographic Characteristics of the Study Sample
Characteristics
Gender
Male
Female
Age bracket
35-40
40-50
50-60
60-70
70-80
80 and above
Ethnicity
Chinese
Filipino
Vietnamese
Asian Indian
Korean
Taiwanese
Japanese
Singaporean
Smoking status
Yes
No
Hypertension
Yes
No
Snoring
Yes
No
OSA
Yes
No

N

%

278
184

60.2
39.8

49
75
80
107
114
36

10.5
16.1
17.2
23.0
24.5
7.7

220
139
37
48
5
4
8
1

47.6
30.1
8.0
10.4
1.1
0.865
1.7
0.216

96
366

20.8
79.2

319
143

69.0
31.0

454
8

98.3
1.7

416
46

90.0
10.0

More than half of the sampled populations were males, about 60.2%, and only
39.8% were females. A larger proportion of the population falls between the ages of 70
and 80 years of age (24.5%), while there were few participants that were 80 years and
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above (7.7%). The mean age of the sampled population is 61 years old. The percentages
of the sampled population were as follows: Chinese (47.6%), Filipinos (30.1%), Asian
Indians (10.4%), Vietnamese (8.0%), Japanese (1.7%), and Korean (1.1%). There were
very few Taiwanese (0.865%) and Singaporeans (0.216%). Table 6 provides the
demographic characteristics of the sampled population.
Table 5
Demographic Characteristics of the Sampled Population
Variables
Gender
Age
Ethnicity
Smoking
status
Systolic
Diastolic
Neck
circumference
BMI
Snoring
Epworth scale
Mallampati
score
AHI
OSA
AHI
GROUPS
Valid N(list
wise)

n
462
462
457
462

Sum
278
28355.00
882
96

Statistic
.60
61.3745
1.93
.21

Mean SE
0.023
.69522
0.58
0.019

SD
.490
14.94315
1.232
.406

Variance
.240
223.298
1.517
.165

462
462
462

57802
34657
6739.3

125.11
75.02
14.587

.679
.469
.0932

14.598
10.080
2.0028

213.098
101.616
4.011

462
462
462
462

12300.53
454
5618
1714

26.6245
.98
12.16
3.71

.24190
.006
.206
.028

5.19939
.131
4.432
.606

27.034
.017
19.640
.367

462
462
462

14504.2
416
1024

31.394
.90
2.22

1.1910
.014
.061

25.600
.300
1.303

655.362
.090
1.697

457

Note. BMI= body mass index; AHI = Apnea-Hypopnea Index

There were 366 non-smokers compared to 96 smokers. 319 patients were
hypertensives compared to 143 non hypertensive patients. The mean systolic blood
pressure of the sampled patients is 125 mmHg and mean diastolic blood pressure is 75
mmHg. The subjects had a mean neck circumference of 14.58 cm; body mass index
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average of 26.62; Epworth Sleepiness Scale average of 12.16; average Mallampati score
of 3.71, and mean Apnea-Hypopnea Index of 31.39. The majorities of the participants
were snorers (98.3%) and diagnosed with obstructive sleep apnea (90%). Table 7 below
provides the descriptive summary of the Apnea Hypopnea Index (AHI) groups of the
study.
Table 6
Apnea Hypopnea Index (AHI) Groups
AHI
Under 5.999
6-14.999
15-29.999
30-49.999
Over 50
Total

Frequency
60
76
126
104
96
462

%
13.0
16.5
27.3
22.5
20.8
100.0

Valid %
13.0
16.5
27.3
22.5
20.8
100.0

Cumulative %
13.0
29.4
56.7
79.2
100.0
100.0

Note. AHI = Apnea-Hypopnea Index
Research question 1. What was the association between OSA and hypertension
among a sample of middle aged Asians living in San Jose, CA?
A binary logistic regression analysis was conducted to determine the association
between OSA and hypertension among a sample of middle aged Asians living in San
Jose, CA. There were 462 cases included in the analysis.
Table 8 below illustrates the logistic coefficient, Wald test and odds ratio for the
predictor variable which is hypertension. Using a .05 criterion for statistical significance,
in a sample of middle aged Asians living in San Jose, CA, hypertension had no
significant association with OSA, x2 (1, N = 462) = .065. p =.799.
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Table 7
Logistic Regression Analysis to Determine Association Between OSA and Hypertension
Variables in equation

Step 1a

OSA(1)
Constant

B

S.E

Wald

df

Sig

Exp(B)

.085
.726

.332
.315

.066
5.327

1
1

.798
.021

1.089
2.067

95%
C.I. for
EXP(B)
Lower
.568

Upper
2.087

Note. S.E. = standard error; df = degrees of freedom; Sig = significance; C.I. =
confidence interval. a.Variable (s) entered on Step 1:OSA

In this analysis, the confidence interval for the variable hypertension (OR = .919)
ranges from .568 to 2.087. Based from this analysis, I failed to reject the null hypothesis.
There was no association between OSA and hypertension among a sample of middle
aged Asian living in San Jose, CA.
Research question 2.

What is the association between age and hypertension

among a sample of middle aged Asians living in San Jose, CA?
A binary logistic regression analysis was conducted to determine the association
between age and hypertension among a sample of middle aged Asian living in San Jose,
CA. There were 462 cases included in the analysis. Table 9 showed the logistic
coefficient, Wald test and odds ratio of the predictor.
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Table 8
Logistic Regression Analysis Between Age and Hypertension
Variables in equation
B

Step
1a

S.E

Wald

df

Sig.

Exp(B)

Age

.089

.009

93.792

1

.000

1.093

Constant

-4.362

.524

69.205

1

.000

.013

95%
C.I. for
EXP
(B)
Lower

Upper

1.093

1.112

Note. S.E. = standard error; df = degrees of freedom; Sig = significance; C.I. =
confidence interval. a.Variable (s) entered on Step 1: Age
Using a .05 criterion for statistical significance, in a sample of middle aged
Asians living in San Jose, CA, age had significant association with hypertension, x2 (1, N
= 462) = 127.932, p < .000. Age recorded an odds ratio of 1.093. This indicated that
older middle age Asians living in San Jose, CA were 1 time more likely to be
hypertensive compared to younger middle age Asians.
Based from this analysis, I rejected the null hypothesis and therefore accepted the
alternative hypothesis. There was an association between age and hypertension among a
sample of middle aged Asians living in San Jose, CA.
Research question 3. What is the association between gender and hypertension
among a sample of middle aged Asians living in San Jose, CA?
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A binary logistic regression analysis was conducted to determine the association
between gender and hypertension among a sample of middle aged Asians living in San
Jose, CA. There were 462 cases included in the analysis.
Table 10 showed the logistic coefficient, Wald test and odds ratio of the predictor.
Table 9
Logistic Regression Analysis Between Gender and Hypertension
Variables in equation
B

Step 1a

S.E

Wald

df

Sig

Exp(B)

95%C.I
for EXP
(B)
Lower
.430

Gender

-.430

.211

4.160

1

.041

.650

Constant

1.070

.169

40.053

1

.000

2.915

Upper
.983

Note. S.E. = standard error; df = degrees of freedom; Sig = significance; C.I. =
confidence interval. a.Variable(s) entered on Step 1: Gender
Using a .05 criterion for statistical significance, in a sample of middle aged
Asians living in San Jose, CA, gender had no significant association with hypertension, x2
(1, N = 462) = 4.245, p = .039. Gender recorded an odds ratio of .650. Based from this
analysis, I failed to reject the null hypothesis.
Research question 4. What is the association between smoking status and
hypertension among a sample of middle aged Asians living in San Jose, CA?
A binary logistic regression analysis was conducted to determine the association
between smoking status and hypertension among a sample of middle aged Asians living
in San Jose, CA. There were 462 cases included in the analysis.
Table 11 showed the logistic coefficient, Wald test and odds ratio of the predictor.
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Table 10
Logistic Regression Analysis Between Smoking Status and Hypertension
Variables in equation
B

Step
1a

Smoking
Status
Constant

S.E

Wald

df

Sig

Exp(B)

-.139

.245

.321

1

.571

.871

.832

.114

53.500

1

.000

2.297

95%
C.I for
EXP
(B)
Lower

Upper

.539

1.406

Note. S.E. = standard error; df = degrees of freedom; Sig = significance; C.I. =
confidence interval. a.Variable (s) entered on Step 1:Smoking status
Using a .05 criterion for statistical significance, in a sample of middle aged
Asians living in San Jose, CA, smoking status had no significant association with
hypertension, x2 (1, N = 462) = 3.18, p = .573. Smoking status recorded an odds ratio of
.871. Based from this analysis, I failed to reject the null hypothesis.
Research question 5. What is the association between body mass index (BMI)
and hypertension among a sample of middle aged Asians living in San Jose, CA?
A binary logistic regression analysis was conducted to determine the association
between body mass index (BMI) and hypertension among a sample of middle aged
Asians living in San Jose, CA. There were 462 cases included in the analysis.
Table 12 showed the logistic coefficient, Wald test and odds ratio of the predictor.
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Table 11
Logistic Regression Analysis Between BMI and Hypertension
Variables in equation
B

Step 1a

S.E.

Wald

df

Sig.

Exp(B)

BMI

-.025

.019

1.775

1

.183

.975

Consta
nt

1.480

.520

8.085

1

.004

4.392

95%
C.I for
EXP
(B)
Lower
.939

Upper
1.012

Note. BMI= body mass index; S.E. = standard error; df = degrees of freedom; Sig =
significance; C.I. = confidence interval. a.Variable(s) entered on Step 1:BMI
Using a .05 criterion for statistical significance, in a sample of middle aged
Asians living in San Jose, CA, BMI had no significant association with hypertension, x2
(1, N = 462) = 1.768, p = .184. BMI recorded an odds ratio of .975. Based from this
analysis, I failed to reject the null hypothesis.
Research question 6. What is the association between Mallampati Score (MS)
and hypertension among a sample of middle aged Asians living in San Jose, CA?
A binary logistic regression analysis was conducted to determine the association
between Mallampati Score (MS) and hypertension among a sample of middle aged
Asians living in San Jose, CA. There were 462 cases included in the analysis.
Table 13 showed the logistic coefficient, Wald test and odds ratio of the predictor.
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Table 12
Logistic Regression Analysis Between Mallampati Score and Hypertension
Variables in equation
B

Step 1a

S.E.

Wald

df

Sig.

Exp(B)

Mallampati

.251

.159

2.479

1

.115

1.285

Constant

-.125

.595

.044

1

.834

.882

95%
C.I. for
EXP
(B)
Lower
.940

Upper
1.757

Note. S.E. = standard error; df = degrees of freedom; Sig = significance; C.I. =
confidence interval. a.Variable(s) entered on Step 1:Mallampati

Using a .05 criterion for statistical significance, in a sample of middle aged
Asians living in San Jose, CA, Mallampati Score had no significant association with
hypertension, x2 (1, N = 462) = 1.768, p = .184. Mallampati Score recorded an odds ratio
of 1.285. Based from this analysis, I failed to reject the null hypothesis.
Research question 7. What is the association between Epworth Sleepiness Scale
(ESS) and hypertension among a sample of middle aged Asian living in San Jose, CA?
A binary logistic regression analysis was conducted to determine the association
between Epworth Sleepiness Scale (ESS) and hypertension among a sample of middle
aged Asian living in San Jose, CA. There were 462 cases included in the analysis.
Table 14 showed the logistic coefficient, Wald test and odds ratio of the predictor.
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Table 13
Logistic Regression Analysis Between Epworth Sleepiness Scale
Variables in equation
B

Step 1a

Epworth
Constant

-.039
1.282

S.E.

.023
.306

Wald

2.821
17.534

df

1
1

Sig.

.093
.000

Exp (B)

.962
3.604

95%
C.I. for
EXP
(B)
Lower

Upper

.919

1.007

Note: S.E. = standard error; df = degrees of freedom; Sig = significance; C.I. =
confidence interval. a.Variable(s) entered on Step 1:Epworth
Using a .05 criterion for statistical significance, in a sample of middle aged
Asians living in San Jose, CA, Epworth Sleepiness Scale had no significant association
with hypertension, x2 (1, N = 462) = 2.870. p = .090. Epworth Sleepiness Scale recorded
an odds ratio of .962. Based from this analysis, I failed to reject the null hypothesis.
Research question 8. What is the association between Apnea-Hypopnea Index
(AHI) and hypertension among a sample of middle aged Asians living in San Jose, CA?
A binary logistic regression analysis was conducted to determine the association
between Apnea-Hypopnea Index (AHI) and hypertension among a sample of middle aged
Asians living in San Jose, CA. There were 462 cases included in the analysis.
Table 15 showed the logistic coefficient, Wald test and odds ratio of the predictor.
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Table 14
Logistic Regression Analysis Between Apnea-Hypopnea Index (AHI) and Hypertension
Variables in equation
B

Step 1a

AHI
Constant

-.001
.835

S.E

.004
.159

Wald

.071
27.491

df

Sig

1
1

.789
.000

Exp(B)

95%C.I
for
EXP(B)
Lower

.999
2.305

Upper

.991

1.007

Note: AHI = Apnea-Hypopnea Index; S.E. = standard error; df = degrees of freedom; Sig
= significance; C.I. = confidence interval. a.Variable (s) entered on Step 1:AHI
Using a .05 criterion for statistical significance, in a sample of middle aged
Asians living in San Jose, CA, Apnea Hypopnea Index had no significant association
with hypertension, x2 (1, N = 462) = 6.974. p = .790. Apnea Hypopnea Index recorded an
odds ratio of .999. Based from this analysis, I failed to reject the null hypothesis.
A multiple regression analysis was conducted to determine the association of
OSA and other risk factors as related to hypertension among middle-aged (40-60+ years
old) Asians living in San Jose, CA. There were 462 cases included in the analysis. Table
16 showed the logistic coefficient, Wald test and odds ratio of the predictors. Table 16
below summarizes the results of the multiple logistic regression analysis.
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Table 15
Summary of Results of the Logistic Regression Analysis
Variables in equation
B

Step 1a

OSA(1)
Age
Gender
Smoking
status
BMI
Mallampati
Epworth
Scale
AHI
Constant

S.E.

Wald

df

Sig

Exp(B)

95%
C.I.for
EXP(
B)
Lower

Upper

-.541
.099
.396
-.245

.457
.011
.282
.302

1.400
87.808
1.972
.660

1
1
1
1

.237
.000
.160
.417

.582
1.104
1.486
.783

.237
1.082
.855
.433

1.427
1.128
2.581
1.414

.043
.481
-.025

.024
.204
.027

3.232
5.541
.866

1
1
1

.072
.019
.352

1.044
1.618
.975

.996
1.084
.926

1.095
2.414
1.028

-.005
7.166

.005
1.320

.733
29.490

1
1

.392
.000

.995
.001

.985

1.006

Note. OSA= obstructive sleep apnea; AHI = Apnea-Hypopnea Index; BMI= body mass
index; S.E. = standard error; df = degrees of freedom; Sig = significance; C.I. =
confidence interval. a.Variable(s) entered on Step 1: OSA, Age, Gender, Smoking status,
BMI , Mallampati score, Epworth Scale, AHI
Using a .05 criterion for statistical significance, in a sample of middle-aged
Asians living in San Jose, CA, age had significant association with hypertension, p =
.000. Age recorded an odds ratio of 1.104. Mallampati score had also a significant
association with hypertension, p = .019. Mallampati score recorded an odds ratio of
1.618. Based from this analysis, age and Mallampati score had significant association to
OSA in relation to hypertension.
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Summary
This quantitative cross sectional study showed that OSA is associated with
hypertension among middle aged Asians living in San Jose, CA. This result were based
from the analysis of electronic and paper medical records of 462 patients randomly
selected from three sleep study centers in San Jose, CA. The logistic regression analysis
also determined the prevalence rate of OSA in association with hypertension together
with other risk factors including age, gender, smoking status, ESS, BMI, MSS, and AHI.
The model containing the eight variables (OSA, age, gender, smoking status, BMI,
Mallampati score, Epworth Sleepiness Scale, and Apnea-Hypopnea Index) were
statistically significant, x2 (8, N = 462) = 139.549, p < .000. The model as a whole
explained 26.1% (Cox and Snell R square) and 36.7% (Nagelkerke R squared) of the
variance in OSA association with hypertension and correctly classified 79.2% of the
cases. Age was the strongest predictor. Based from the results of the multiple logistic
regression analysis, age and Mallampati score had significant association to OSA in
relation to hypertension among middle-aged Asians living in San Jose, CA.
The next chapter will provide the discussion, conclusion and recommendations
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Chapter 5: Discussion, Conclusions, and Recommendations
Introduction
The goal of this study was to understand the prevalence of OSA and hypertension
among Asians. There are no published scientific reports on the general prevalence of
OSA among Asians. OSA poses significant CVD burden. This imposes an important
health crisis in a county of Santa Clara, where out of the 18 million residents 33.7% are
Asians (U.S Census Data, 2012). In order to understand the burden of these diseases,
there is a need to understand what the prevalence of OSA and hypertension among
Asians is. Hence, the purpose of the study was to address this gap and to determine the
role of other risk factors, such as age, gender, smoking, body mass index (BMI),
Mallampati score (MS), Epworth Sleepiness Scale (ESS), and Apnea-Hypopnea Index
(AHI), that influence the prevalence rate of OSA and its association with hypertension
among middle aged Asians residing in San Jose, CA.
This chapter provides the summation of the findings, conclusions, and
recommendations based on the results on the quantitative cross-sectional study of the
prevalence of OSA among middle aged Asians in Santa Clara County using paper and
electronic medical records. Data collection started in July 2014 and ended in October
2014. In order to ensure that data interpretation and analysis were impartial, I used
logistic regression analysis to determine the prevalence of OSA and the association of
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different variables. The odds ratios (ORs) of OSA association with hypertension were
calculated for ethnicity, age, gender, smoking, BMI, MSS, ESS, and AHI.
Descriptive statistics were performed in the defined categorical variables in the
study. Frequency tabulation was used for gender, sex, race, smoking, and alcohol
history, elevated blood pressure, and history of hypertension. Descriptive statistics for
continuous variables (e.g., age) which enlisted the summary statistics included n, mean,
median, standard deviation, and range. The study also included the use of tables to
describe and explore the data.
Statement of the Problem
The main purpose of this quantitative cross-sectional study was to determine (a)
the prevalence rate of OSA among middle-aged Asian patients (Chinese, Filipino,
Vietnamese, Asian Indians, Korean, Taiwanese, Japanese, and Singaporean) in San Jose,
CA.; (b) the association between OSA and hypertension, and (c) the association of other
risk factors: age, gender, smoking, body mass index (BMI); Mallampati score (MS), the
Epworth Sleepiness Scale (ESS), and Apnea-Hypopnea Index (AHI) with hypertension as
the outcome.
This quantitative cross-sectional study showed that OSA is associated with
hypertension among middle-aged Asians living in San Jose, CA. This result were based
from the analysis of paper and electronic medical records of 462 patients randomly
selected from three sleep study centers in San Jose, CA. The logistic regression analysis
also determined the prevalence rate of OSA in association with hypertension together
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with other risk factors including age, gender, smoking status, ESS, BMI, MSS, and AHI.
The model containing the eight variables (OSA, age, gender, smoking status, BMI,
Mallampati score, Epworth Sleepiness Scale, Apnea-Hypopnea Index) was statistically
significant, x2 (8, N = 462) = 139.549, p < .000. The model as a whole explained 26.1%
(Cox and Snell R square) and 36.7% (Nagelkerke R squared) of the variance in OSA
association with hypertension and correctly classified 79.2% of the cases. Age was the
strongest predictor.
Interpretation of Findings
The results of this study established verifications from other studies that OSA is
common and associated with hypertension among Asian patients. Similarly, this study
also showed that among Asian patients with OSA, the association with hypertension is
significantly increased with advancing age (Bixler et al., 2000; Drager et al., 2010;
Young et al., 2004). This study also adds further proof that weight as measured by body
mass index (BMI) is not highly associated among OSA Asian patients with hypertension
compared to other OSA Caucasian patients with hypertension (Kim et al., 2013; Hla et
al., 1994, Yoon, et al., 2009). This particular finding was a stark contrast to the findings
by Min et al., (2014). Min et al., 2014 found that among men with moderate to severe
OSA, age was not associated with hypertension while neck circumference was positively
correlated with OSA associated hypertension (Hla et al., 1994, p. 1310). Additionally,
gender, smoking status, Mallampati score, Epworth Sleepiness Scale, and ApneaHypopnea Index had no significant association among OSA Asian patients with
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hypertension. However, Mallampati Score (MS) showed a trend towards suggesting that
this particular risk factor could be considered as an important diagnostic tool in
evaluating Asian patients with OSA and hypertension. This particular finding supported
the research findings by Li et al., (2000). According to that study, the shorter anterior
cranial base and acute cranial base flexure are more common among Far East Asian men
compared to Caucasian men contributed to the high degree of association between OSA
with hypertension (Li et al., 2000, p. 1691).
The findings from this study supported the evidence that OSA is prevalent among
Asians. The study also showed that there is an association of OSA with hypertension.
Given such association between OSA and hypertension among Asians, Asian patients
should be screened, diagnosed, and treated appropriately to reduce the significant
cardiovascular burden of this disease in the community.
Limitations of the Study
A limitation of the current study was that subjects were only sampled in Santa
Clara County. Additionally, the sample size was small. Due to time and financial
constraints, the study had to employ data obtained from paper and electronic medical
records that were basically designed for clinical care and not research. EMR was used
because it provided easy access to patient data, large cohorts, patient level diagnosis,
treatment data, billing and laboratory information. However, limitations in the use of
electronic medical records include information entered being decided by the provider,
information entered in free text, scanned images, flexibility in terminology, a minimal
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number of required fields, and unimportant data irrelevant to clinical care is missing
(Terry et al., 2010). Another limitation of the use of secondary data is the lack of clinical
detail (Gallin & Ognibene, 2012). This is especially true because certain EMR data sets
contained clinical data relevant to physician payments (Gallin & Ognibene, 2012, p. 375).
Another limitation of cross-sectional studies similar to this one is the inability of the
researcher to provide a temporal sequence of the exposure and the outcome (Ho et al.,
2008). The limitations associated with this data analysis also included variation in
software platforms used by each clinic for their EMR systems, medical terminology, and
clinical data, i.e., laboratory results, and units of measurements (Dean et al., 2009).
However, the potential bias in the use of EMR as a source of secondary data was
minimized by the random sampling of the subjects and the rigorous adherence to study
protocol. Additionally, this study did not include participants’ medical information such
as medication use, patients’ medical history, sleep time, and other factors that might
affect the association of OSA with hypertension. The homogeneousness of the study
population, the sample size, and the sampling convenience overall limited the
generalizability of this study.
Recommendations
Prospective studies involving bigger cohorts should be conducted to determine
accurately the prevalence of OSA among Asian patients compared to White populations.
Ideally, future research should include analysis of the association of OSA and
hypertension should be conducted among Asian and Caucasian patients while controlling
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for age, gender, smoking status, body mass index (BMI), Mallampati score (MS),
Epworth Sleepiness Scale (ESS), and Apnea Hypopnea Index (AHI).
Social Change
This study fostered to the epidemiologic understanding of OSA as the
independent variable and hypertension as an outcome among middle aged Asians in San
Jose, CA. This study conducted a research on a disease that can generate valuable public
health insight to the consequence of this disease to cardiovascular health among high risk
middle-aged Asians. This is critically important especially when studies involving OSA
does not adequately synthesized or provide clarity into the health differences among
Asian Americans. Because there are still a great number of underdiagnosed and
undertreated Asian patients in San Jose, CA, the results generated from this research can
lead to successful physician identification, screening, treatment, and management of OSA
and hypertension especially among high risks middle-aged Asians, thus creating positive
social change for those individuals, their families, and their communities. This study can
advance social change by providing more justification for the need to conduct prospective
large scale OSA studies among this vulnerable patient population who are definitely at
risk for OSA and its health consequence. This study can also advance social change by
empowering this ethnic group to advocate for themselves and collectively challenge
service providers, government agencies and other institutions to ensure equal access to
healthcare, and available services. Additionally, the results of this study would also
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encourage positive social change by improving the health outcomes and the lives of
Asians who have been suffering from OSA and hypertension for a long time.
Conclusions
OSA is common among middle aged Asians. OSA does increase the risk for
hypertension among middle aged Asians in Santa Clara County. This quantitative crosssectional study showed that OSA is associated with hypertension among middle aged
Asians living in San Jose, CA. This particular research is very meaningful especially
knowing that there are a number of Asians living in Santa Clara County that remains
undiagnosed and untreated. The question that remains, that possibly could be answered
by other research, is what else aside from age that one should consider as an important
risk factor for this disease.
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Apnea and Hypertension among Middle-aged Asians." conditional upon the approval of
the community research partners, which will need to be documented in signed data use
agreements. Walden's IRB approval only goes into effect once the Walden IRB confirms
receipt of those data use agreements.

Your approval # is 03-25-14-0153639. You will need to reference this number in
your dissertation and in any future funding or publication submissions.

Your IRB approval expires on March 24, 2015. One month before this expiration
date, you will be sent a Continuing Review Form, which must be submitted if you wish to
collect data beyond the approval expiration date.

Please note that this letter indicates that the IRB has approved your research. You
may NOT begin the research phase of your doctoral study, however, until you have
received the Notification of Approval to Conduct Research e-mail. Once you have
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received this notification by email, you may begin your data collection. Your IRB
approval is contingent upon your adherence to the exact procedures described in the final
version of the IRB application materials that have been submitted as of this date. This
includes maintaining your current status with the university. Your IRB approval is only
valid while you are an actively enrolled student at Walden University. If you need to take
a leave of absence or are otherwise unable to remain actively enrolled, your IRB approval
is suspended. Absolutely NO participant recruitment or data collection may occur while a
student is not actively enrolled.

Your IRB approval is contingent upon your adherence to the exact procedures
described in the final version of the IRB application materials that have been submitted as
of this date. If you need to make any changes to your research staff or procedures, you
must obtain IRB approval by submitting the IRB Request for Change in Procedures
Form. You will receive confirmation with a status update of the request within 1 week of
submitting the change request form and are not permitted to implement changes prior to
receiving approval. Please note that Walden University does not accept responsibility or
liability for research activities conducted without the IRB's approval, and the University
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will not accept or grant credit for student work that fails to comply with the policies and
procedures related to ethical standards in research.

When you submitted your IRB application, you a made commitment to
communicate both discrete adverse events and general problems to the IRB within 1
week of their occurrence/realization. Failure to do so may result in invalidation of data,
loss of academic credit, and/or loss of legal protections otherwise available to the
researcher.

Both the Adverse Event Reporting form and Request for Change in Procedures
form can be obtained at the IRB section of the Walden web site or by emailing
irb@waldenu.edu:
http://inside.waldenu.edu/c/Student_Faculty/StudentFaculty_4274.htm.

Researchers are expected to keep detailed records of their research activities (i.e.,
participant log sheets, completed consent forms, etc.) for the same period of time they
retain the original data. If, in the future, you require copies of the originally submitted
IRB materials, you may request them from Institutional Review Board.
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Both students and faculty are invited to provide feedback on this IRB experience
at the link below:

http://www.surveymonkey.com/s.aspx?sm=qHBJzkJMUx43pZegKlmdiQ_3d_3d

Sincerely,

Jenny Sherer, M.Ed., CIP
Associate Director
Office of Research Ethics and Compliance
irb@waldenu.edu
Phone: 612-312-1341
Fax: 626-605-0472
Office address for Walden University:
100 Washington Avenue South
Suite 900
Minneapolis, MN 55401

